［1］Abhimanyu and A. K. Coussens. “The Role of UV Radiation and Vitamin D in the Seasonality and Outcomes of Infectious Disease”. Photochemical and Photobiological Sciences 16，no.3 （2017）：314-38. ［2］Adams，F. The Genuine Works of Hippocrates. New York：William Wood，1886. ［3］Aimone，F. “The 1918 Influenza Epidemic in New York City：A Review of the Public Health Response”. Public Health Reports 125，suppl.3 （2010）：71-79. ［4］Almond，D. “Is the 1918 Influenza Pandemic Over？Long-Term Effects of InUtero Influenza Exposure in the Post-1940 U.S. Population”. Journal of Political Economy 114，no.41 （2006）：672-712. ［5］Andrews，C. The Common Cold. New York：W. W. Norton，1965. ［6］Barry，J. M. The Great Influenza：The Epic Story of the Deadliest Plague in History. New York：Penguin，2005. ［7］Barry，J. M. “The Site of Origin of the 1918 Influenza Pandemic and Its Public Health Implications”. Journal of Translational Medicine 2，no.1 （2004）：3. ［8］Bergman，P.，A. U. Lindh，L. Bjorkhem-Bergman，and J. D. Lindh. “Vitamin Dand Respiratory Tract Infections：A Systematic Review and Meta-analysis of Randomized Controlled Trials”. PLoS One 8，no.6 （2013）：e65835. ［9］Blair，G. The Trumps：Three Generations That Built an Empire. New York：Touchstone，2000. ［10］Boland，M. E.，S. M. Roper，and J. A. Henry. “Complications of Quinine Poisoning”. Lancet 325，no.8425 （1985）：384-85. ［11］Brett，A. S.，and A. Zuger.，“The Run on Tamiflu—Should Physicians Prescribeon Demand？” New England Journal of Medicine 353，no.25 （2005）：2636-37. ［12］Bridges，C. B.，W. W. Thompson，M. I. Meltzer，G. R. Reeve，W. J. Talamonti，N. J. Cox，H. A. Lilac，H. Hall，A. Klimov，and K. Fukuda. “Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults：A Randomized Controlled Trial”. JAMA 284，no.13 （2000）：1655-63. ［13］Brownstein，J. S.，C. J. Wolfe，and K. D. Mandl.，“Empirical Evidence for the Effect of Airline Travel on Inter-regional Influenza Spread in the United States”. PLoS Medicine 3，no.10 （2006）：e401. ［14］Butler，D.，“When Google Got Flu Wrong”. Nature 494，no.7436 （2013）：155-56. ［15］Byerly，C.，Fever of War：The Influenza Epidemic in the U.S. Army during WorldWar I. New York：New York University Press，2005. ［16］Cannell，J. J.，R. Vieth，J. C. Umhau，M. F. Holick，W. B. Grant，S. Madronich，C. F.，Garland，and E. Giovannucci. “Epidemic Influenza and Vitamin D”. Epidemiology & Infection 134，no.6 （2006）：1129-40. ［17］Cello，J.，A. V. Paul，and E. Wimmer. “Chemical Synthesis of Poliovirus cDNA：Generation of Infectious Virus in the Absence of Natural Template”. Science297，no.5583 （2002）：1016-18. ［18］Centers for Disease Control and Prevention. “Update：Drug Susceptibility of Swine-Origin Influenza A （H1N1）Viruses，April 2009”. Morbidity and Mortality Weekly Report 58，no.16 （2009）：433-35. ［19］Chartrand，C.，M. M. Leeflang，J. Minion，T. Brewer，and M. Pai. “Accuracy of Rapid Influenza Diagnostic Tests：A Meta-analysis”. Annals of Internal Medicine 156，no.7 （2006）：500-11. ［20］Collier，R. The Plague of the Spanish Lady：The Influenza Pandemic of 1918-1919. London：Macmillan，1974. ［21］Cook，S.，C. Conrad，A. L. Fowlkes，and M. H. Mohebbi. “Assessing Google FluTrends Performance in the United States during the 2009 Influenza Virus A （H1N1）Pandemic”. PLoS One 6，no.8 （2011）：e23610. ［22］Cooper Cole，C. E. “Preliminary Report on Influenza Epidemic at Bramshott inSeptember-October，1918”. British Medical Journal 2，no.3021 （1918）：566-68. ［23］Creighton，C. A History of Epidemics in Britain. New York：Barnes & Noble，1965. ［24］Crosby，A. W. America’s Forgotten Pandemic：The Influenza of 1918. Cambridge：Cambridge University Press，2003. ［25］Das，D.，K. Mertzger，R. Heffernan，S. Balter，D. Weiss，and F. Mostashari. “Monitoring Over-the-Counter Medication Sales for Early Detection of Disease Outbreaks—New York City”. MMWR Supplements 54 （2005）：41-46. ［26］Debauche，L. Reel Patriotism：The Movies and World War I. Madison：Universityof Wisconsin Press，1997. ［27］Demicheli，V.，T. Jefferson，L. A. Al-Ansary，E. Ferroni，and C. Di Pietrantonj. “Vaccines for Preventing Influenza in Healthy Adults”. Cochrane Database of Systematic Reviews 3 （2014）：CD001269. ［28］Dobson，J.，R. J. Whitley，S. Pocock，and A. S. Monto. “Oseltamivir Treatment for Influenza in Adults：A Meta-analysis of Randomised Controlled Trials”. Lancet 385，no.9979 （2015）：1729-37. ［29］Doshi，P. “The Elusive Definition of Pandemic Influenza”. Bulletin of the World Health Organization 89 no.7 （2011）：532-38. ［30］Doshi，P. “The 2009 Influenza Pandemic”. Lancet Infectious Diseases 13，no.3 （2013）：193. ［31］Dow，K.，and S. Cutter. “Crying Wolf：Repeat Responses to Hurricane EvacuationOrders”. Coastal Management 26，no.4 （1998）：237-52. ［32］Duncan，K. Hunting the 1918 Flu：One Scientist’s Search for a Killer Virus. Toronto：University of Toronto Press，2003. ［33］Earn，D. J.，P. W. Andrews，and B. M. Bolker. “Population-Level Effects of Suppressing Fever”. Proceedings of the Royal Society B：Biological Sciences 281，no.1778 （2014）：20132570. ［34］Edmond，J. D.，R. G. Johnston，D. Kidd，H. J. Rylance，and R. G. Sommerville. “The Inhibition of Neuraminidase and Antiviral Action”. British Journal of Pharmacology and Chemotherapy 27，no.2 （1966）：415-26. ［35］Emerman，M.，and H. S. Malik. “Paleovirology—Modern Consequences of AncientViruses”. PLoS Biology 8，no.2 （2010）：e1000301. ［36］Emerman，M.，and H. S. Malik. “The Epidemic of Influenza”. JAMA 71，no.13 （1918）：1063-64. ［37］Evans，S. S.，E. A. Repasky，and D. T. Fisher. “Fever and the Thermal Regulation of Immunity：The Immune System Feels the Heat”. Nature Reviews Immunology 15，no.6 （2015）：335-49. ［38］Eyler，J. M. “The State of Science，Microbiology，and Vaccines circa 1918”. Public Health Reports 125，suppl.3 （2010）：27-36. ［39］Fabier，F. “Traitement de la Grippe par les Injections de Quinine”. Journal de Médecineet de Chirurgie Pratiques 90 （1919）：783-84. ［40］Fiore，A. E.，T. M. Uyeki，K. Broder，L. Finelli，G. L. Euler，J. A. Singleton，J. K. Iskander et al. “Prevention and Control of Influenza with Vaccines：Recommendations of the Advisory Committee on Immunization Practices （ACIP），2010”. MMWR Recommendations and Reports 59，no. RR-8 （2010）：1-62. ［41］Garrett，T. “Pandemic Economics：The 1918 Influenza and Its Modern-Day Implications”. Federal Reserve Bank of St. Louis Review 90，no.2 （2008）：75-93. ［42］Garrett，T. “War and Pestilence as Labor Market Shocks：U.S. Manufacturing WageGrowth 1914-1919”. Economic Inquiry 47，no.4 （2009）：711-25. ［43］Gaydos，J. C.，F. H. Top Jr.，R. A. Hodder，and P. K. Russell. “Swine Influenza AOutbreak，Fort Dix，New Jersey，1976”. Emerging Infectious Diseases 12，no.1 （2006）：23-28. ［44］Gerdil，C. “The Annual Production Cycle for Influenza Vaccine”. Vaccine 21，no.16 （2003）：1776-79. ［45］Glatstein，M.，and D. Scolnik. “Fever：To Treat or Not to Treat？” World Journal of Pediatrics 4，no.4 （2008）：245-47. ［46］Godlee，F. “Conflicts of Interest and Pandemic Flu”. British Medical Journal 340 （2010）：c2947. ［47］Gregor，A. “A Note on the Epidemiology of Influenza among Workers”. British Medical Journal 1，no.3035 （1919）：242-43. ［48］Grijalva，C. G.，J. P. Nuorti，and M. R. Griffin. “Antibiotic Prescription Rates for Acute Respiratory Tract Infections in U.S. Ambulatory Settings”. JAMA 302，no.7 （2009）：758-66. ［49］Grist，N. R. “Pandemic Influenza 1918”. British Medical Journal 2，no.6205 （1979）：1632-33. ［50］Gross，C. P.，and K. A. Sepkowitz. “The Myth of the Medical Break through：Small pox，Vaccination，and Jenner Reconsidered”. International Journal of Infectious Disease 3，no.1 （1998）：54-60. ［51］Hammond，G. W.，R. L. Raddatz，and D. E. Gelskey. “Impact of Atmospheric Dispersionand Transport of Viral Aerosols on the Epidemiology of Influenza”. Reviews of Infectious Diseases 11，no.3 （1989）：494-97. ［52］Hammond，J. A. B.，W. Rolland，and T. H. G. Shore. “Purulent Bronchitis：A Studyof Cases Occurring amongst the British Troops at a Base in France”. Lancet 190，no.4898 （1917）：41-45. ［53］Hannoun，C. “The Evolving History of Influenza Viruses and Influenza Vaccines”. Expert Review of Vaccines 12，no.9 （2013）：1085-94. ［54］Hawkes，N. “Sharp Spike in Deaths in England and Wales Needs Investigating，Says Public Health Expert”. British Medical Journal 352 （2016）：i981. ［55］Hayden，F. G.，J. J. Treanor，R. F. Betts，M. Lobo，J. D. Esinhart，and E. K. Hussey. “Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza”. JAMA 275，no.4 （1996）：295-99. ［56］Henderson，D. A.，B. Courtney，T. V. Inglesby，E. Toner，and J. B. Nuzzo. “Public Health and Medical Responses to the 1957-58 Influenza Pandemic”. Biosecurityand Bioterrorism 7，no.3 （2009）：265-73. ［57］Herfst，S.，E. J. Schrauwen，M. Linster，S. Chutinimitkul，E. De Wit，V. J. Munster，E. M. Sorrell et al. “Airborne Transmission of Influenza A/H5N1 Virus between Ferrets”. Science 336，no.6088 （2012）：1534-41. ［58］Hernan，M. A.，and M. Lipsitch. “Oseltamivir and Risk of Lower RespiratoryTract Complications in Patients with Flu Symptoms：A Meta-analysis of Eleven Randomized Clinical Trials”. Clinical Infectious Diseases 53，no.3 （2011）：277-79. ［59］Herrick，J. B. “Treatment of Influenza by Means Other Than Vaccines and Serums”. JAMA 73，no.7 （1919）：482-87. ［60］Hiam，L.，D. Dorling，D. Harrison，and M. McKee. “What Caused the Spike in Mortality in England and Wales in January 2015？” Journal of the Royal Society of Medicine 110，no.4 （2017）：131-37. ［61］Hildreth，M. L. “The Influenza Epidemic of 1918-1919 in France：Contemporary Concepts of Aetiology，Therapy，and Prevention”. Social History of Medicine 4，no.2 （1991）：277-94. ［62］Hirani，V.，and P. Primatesta. “Vitamin D Concentrations among People Aged 65 Years and Over Living in Private Households and Institutions in England：Population Survey”. Age and Ageing 34 no.5 （2006）：485-91. ［63］Hirve，S.，L. P. Newman，J. Paget，E. Azziz-Baumgartner，J. Fitzner，N. Bhat，K. Vandemaele，and W. Zhang. “Influenza Seasonality in the Tropics and Subtropics—When to Vaccinate？” PLoS One 11，no.4 （2016）：e0153003. ［64］Honigsbaum，M. “Regulating the 1918-19 Pandemic：Flu，Stoicism and theNorthcliffe Press”. Medical History 57，no.2 （2013）：165-85. ［65］Hopkirk，A. F. Influenza：Its History，Nature，Cause and Treatment. New York：Walter Scott Publishing，1914. ［66］Hoyle，F.，and C. Wickramasinghe. Evolution from Space：A Theory of Cosmic Creationism.New York：Simon & Schuster，1982. ［67］Hoyle，F.，and N. C. Wickramasinghe. “Sunspots and Influenza”. Nature 343，no.6256 （1990）：304. ［68］Hughes，S. S. The Virus：A History of the Concept. London：Heinemann Educational Books，Science History Publications，1977. ［69］Influenza Committee of the Advisory Board to the D.G.M.S.，France. “The Influenza Epidemic in the British Armies in France，1918”. British Medical Journal 2，no.3019 （1918）：505-9. ［70］“Influenza Discussions”. American Journal of Public Health 9，no.2 （1919）：136. ［71］“Influenza：Its History，Nature，Cause and Treatment”. Book review. JAMA 63，no.3 （1914）：267. ［72］“Influenza：Kansas—Haskell”. Public Health Reports 33，no.14 （1918）：502. ［73］Jack，A. “Flu’s Unexpected Bonus”. British Medical Journal 339 （2009）：b3811. “James B. Herrick （1861-1954）”. JAMA 16，no.186 （1963）：722-23. ［74］Jefferson，T. “Influenza Vaccination：Policy versus Evidence”. British Medical Journal 333，no.7574 （2006）：912-15. ［75］Jefferson，T.，V. Demicheli，D. Rivetti，M. Jones，C. Di Pietrantonj，and A. Rivetti. “Antivirals for Influenza in Healthy Adults：Systematic Review”. Lancet 367，no.9507 （2006）：303-13. ［76］Jefferson，T.，and P. Doshi. “Multisystem Failure：The Story of Anti-influenza Drugs”. British Medical Journal 348 （2014）：g2263. ［77］Jefferson，T.，M. A. Jones，P. Doshi，C. B. Del Mar，R. Hama，M. J. Thompson，E. A. Spencer et al. “Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children”. Cochrane Database of Systematic Reviews 4 （2014）：CD008965. ［78］Jenner，E. An Inquiry into the Causes and Effects of the VariolaeVaccinae，a Disease Discovered in Some of the Western Counties of England，Particularly Gloucestershire，and Known by the Name of the Cow Pox. London：Sampson Low，1798. ［79］Kaiser，L.，C. Wat，T. Mills，P. Mahoney，P. Ward，and F. Hayden. “Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complicationsand Hospitalizations”. Archives of Internal Medicine 163，no.14 （2003）：1667-72. ［80］Kamat，S.，V. Maniaci，M. Y. Linares，and J. M. Lozano. “Pediatric Psychiatric Emergency Department Visits during a Full Moon.” Pediatric Emergency Care 30，no.12 （2014）：875-78. ［81］Kelly，H.，and K. Grant. “Interim Analysis of Pandemic Influenza （H1N1）2009 in Australia：Surveillance Trends，Age of Infection and Effectiveness of SeasonalVaccination”. Eurosurveillance 14，no.31 （2009）：1-5. ［82］Kennedy，D. “Better Never Than Late”. Science 310，no.5746 （2005）：195. ［83］Khan，A.，and W. Patrick. The Next Pandemic：On the Front Lines against Humankind’s Gravest Dangers. New York：Public Affairs，2016. ［84］Kilbourne，E. D. “Influenza Pandemics of the 20th Century”. Emerging Infectious Diseases 12，no.1 （2006）：9-14. ［85］Klein，H. A. “The Treatment of ‘Spanish Influenza’”. JAMA 71，no.18 （1918）：1510. ［86］Kluger，M. J. Fever：Its Biology，Evolution，and Function. Princeton，NJ：Princeton University Press，1979. ［87］Kmietowicz，Z. “Use Leftover Tamiflu to Grit Icy Roads，MP Suggests”. British Medical Journal 340 （2010）：c501. ［88］Kochanek，K. D.，S. L. Murphy，J. Xu，and B. Tejada-Vera. “Deaths：Final Data for 2014”. National Vital Statistics Reports 65，no.4 （2016）：1-122. ［89］Kolata，G. Flu：The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It. New York：Touchstone，2005. ［90］Lamb，F.，and E. Brannin. “The Epidemic Respiratory Infection at Camp Cody N.M”. JAMA 72，no.15 （1919）：1056-62. ［91］Langford，C. “Did the 1918-19 Influenza Pandemic Originate in China？” Populationand Development Review 31，no.3 （2005）：479-505. ［92］Langmuir，A. D.，T. D. Worthen，J. Solomon，C. G. Ray，and E. Petersen. “TheThucydides Syndrome. A New Hypothesis for the Cause of the Plague of Athens”. New England Journal of Medicine 313，no.16 （1985）：1027-30. ［93］Lazer，D.，R. Kennedy，G. King，and A. Vespignani. “The Parable of Google Flu：Traps in Big Data Analysis”. Science 343，no.6176 （2014）：1203-5. ［94］Leary，T. “The Use of the Influenza Vaccine in the Present Epidemic”. American Journal of Public Health 8，no.10 （1918）：754-55. ［95］Li，W.，S. K. Wong，F. Li，J. H. Kuhn，I. C. Huang，H. Choe，and M. Farzan. “Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus：Insight from ACE2-S-Protein Interactions”. Journal of Virology 80，no.9 （2006）：4211-19. ［96］Linder，J. A. “Vitamin D and the Cure for the Common Cold”. JAMA 308，no.13 （2012）：1375-76. ［97］Lowen，A. C.，S. Mubareka，J. Steel，and P. Palese. “Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature”. PLoS Pathogens 3，no.10 （2007）：1470-76. ［98］Malik，M. T.，A. Gumel，L. H. Thompson，T. Strome，and S. M. Mahmud. “‘Google Flu Trends’ and Emergency Department Triage Data Predicted the 2009 Pandemic H1N1 Waves in Manitoba”. Canadian Journal of Public Health 102，no.4 （2011）：294-97. ［99］Mamelund，S. E. “A Socially Neutral Disease？Individual Social Class，Household Wealth and Mortality from Spanish Influenza in Two Socially ContrastingParishes in Kristiania 1918-19”. Social Science & Medicine 62，no.4 （2006）：923-40. ［100］McCarthy，M. L.，S. L. Zeger，R. Ding，D. Aronsky，N. R. Hoot，and G. D. Kelen. “The Challenge of Predicting Demand for Emergency Department Services”. Academic Emergency Medicine 15，no.4 （2008）：337-46. ［101］McGuire，A.，M. Drummond，and S. Keeping. “Childhood and Adolescent Influenza Vaccination in Europe：A Review of Current Policies and Recommendations for the Future”. Expert Review of Vaccines 15，no.5 （2016）：659-70. ［102］McOscar，J. “Influenza in the Lay Press”. British Medical Journal 2，no.3019 （1918）：534. ［103］Mitton，S. Fred Hoyle：A Life in Science. Cambridge：Cambridge University Press，2011. ［104］Molinari，N. A.，I. R. Ortega-Sanchez，M. L. Messonnier，W. W. Thompson，P. M.Wortley，E. Weintraub，and C. B. Bridges. “The Annual Impact of Seasonal Influenza in the U.S.：Measuring Disease Burden and Costs”. Vaccine 25，no.27 （2007）：5086-96. ［105］Morens，D. M. “Death of a President”. New England Journal of Medicine 341，no.24 （1999）：1845-49. ［106］Morens，D. M.，and A. S. Fauci. “The 1918 Influenza Pandemic：Insights for the 21st Century”. Journal of Infectious Disease 195，no.7 （2007）：1019-28. ［107］Morens，D. M.，G. K. Folkers，and A. S. Fauci. “What Is a Pandemic？” Journal of Infectious Disease 200，no.7 （2009）：1018-21. ［108］Morens，D. M.，J. K. Taubenberger，and A. S. Fauci. “The Persistent Legacy of the 1918 Influenza Virus”. New England Journal of Medicine 361，no.3 （2009）：225-29. ［109］Moscona，A. “Neuraminidase Inhibitors for Influenza”. New England Journal of Medicine 353，no.13 （2005）：1363-73. ［110］Moser，M. R.，T. R. Bender，H. S. Margolis，G. R. Noble，A. P. Kendal，and D. G.Ritter. “An Outbreak of Influenza aboard a Commercial Airliner”. American Journal of Epidemiology 110，no.1 （1979）：1-6. ［111］Murdoch，D. R.，S. Slow，S. T. Chambers，L. C. Jennings，A. W. Stewart，P. C.Priest，C. M. Florkowski，J. H. Livesey，A. C. Camargo，and R. Scragg. “Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infectionsin Healthy Adults：The Vidaris Randomized Controlled Trial”. JAMA 308，no.13 （2012）：1333-39. ［112］Murray，C. J.，A. D. Lopez，B. Chin，D. Feehan，and K. H. Hill. “Estimation of Potential Global Pandemic Influenza Mortality on the Basis of Vital Registry Data from the 1918-20 Pandemic：A Quantitative Analysis”. Lancet 368，no.9554 （2006）：2211-18. ［113］Murthy，S.，and H. Wunsch. “Clinical Review：International Comparisons in Critical Care—Lessons Learned”. Critical Care 16，no.2 （2012）：218. ［114］Nguyen，J. L.，J. Schwartz，and D. W. Dockery. “The Relationship between Indoor and Outdoor Temperature，Apparent Temperature，Relative Humidity，and Absolute Humidity”. Indoor Air 24，no.1 （2014）：103-12. ［115］Nicolson，J. The Great Silence，1918-1920：Living in the Shadow of the Great War.London：Grove Press，2010. ［116］Noti，J. D.，F. M. Blachere，C. M. McMillen，W. G. Lindsley，M. L. Kashon，D. R.Slaughter，and D. H. Beezhold. “High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs”. PLoS One 8，no.2 （2013）：e57485. ［117］Olitsky，P.，and F. Gates. “Experimental Study of the Nasopharyngeal Secretions from Influenza Patients”. JAMA 74，no.22 （1920）：1497-99. ［118］Opie，E.，A. Freeman，F. Blake，J. Small，and T. Rivers. “Pneumonia at Camp Funston”. JAMA 72，no.2 （1919）：108-13. ［119］Ortiz，J. R.，L. Kamimoto，R. E. Aubert，J. Yao，D. K. Shay，J. S. Bresee，and R. S.Epstein. “Oseltamivir Prescribing in Pharmacy-Benefits Database，United States，2004-2005”. Emerging Infectious Diseases 14，no.8 （2008）：1280-83. ［120］Oshinsky，D. M. Polio：An American Story. Oxford：Oxford University Press，2005. ［121］Oxford，J. S. “The So-Called Great Spanish Influenza Pandemic of 1918 May Have Originated in France in 1916”. Philosophical Transactions of the Royal Society of London，Series B：Biological Sciences 356，no.1416 （2001）：1857-59. ［122］Patterson，K. D. Pandemic Influenza，1700-1900. Totowa，NJ：Rowman and Littlefield，1986. ［123］Patwardhan，A.，and R. Bilkovski. “Comparison：Flu Prescription Sales Data from a Retail Pharmacy in the U.S. with Google Flu Trends and U.S. ILINet （CDC）Data as Flu Activity Indicator”. PLoS One 7，no.8 （2012）：e43611. ［124］Petersen，W. F.，and S. A. Levinson. “The Therapeutic Effect of Venesection with Reference to Lobar Pneumonia”. JAMA 78，no.4 （1922）：257-58. ［125］Polgreen，P. M.，F. D. Nelson，and G. R. Neumann. “Use of Prediction Markets to Forecast Infectious Disease Activity”. Clinical Infectious Diseases 44，no.2 （2007）：272-79. ［126］Prager，F.，D. Wei，and A. Rose. “Total Economic Consequences of an Influenza Outbreak in the United States”. Risk Analysis 37，no.1 （2017）：4-19. ［127］Price，G. M. “Influenza—Destroyer and Teacher”. Survey 41，no.12 （1918）：367-69. ［128］“Proceedings of the Forty-Sixth Annual Meeting of the American Public Health Association”. American Journal of Public Health 9，no.2 （1919）：130-42. ［129］Reichert，T. A.，N. Sugaya，D. S. Fedson，W. P. Glezen，L. Simonsen，and M. Tashiro. “The Japanese Experience with Vaccinating Schoolchildren against Influenza”. New England Journal of Medicine 344，no.12 （2001）：889-96. ［130］Reid，A. H.，T. A. Janczewski，R. M. Lourens，A. J. Elliot，R. S. Daniels，C. L. Berry，J. S. Oxford，and J. K. Taubenberger. “1918 Influenza Pandemic Caused by Highly Conserved Viruses with Two Receptor-Binding Variants”. Emerging Infectious Diseases 9，no.10 （2003）：1249-53. ［131］Rice，E. W.，N. J. Adcock，M. Sivaganesan，J. D. Brown，D. E. Stallknecht，and D. E.Swayne. “Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus （H5N1）”. Emerging Infectious Diseases 13，no.10 （2007）：1568-70. ［132］Riedel，S. “Edward Jenner and the History of Smallpox and Vaccination.” Proceedings （Baylor University Medical Center） 18，no.1 （2005）：21-25. ［133］Robins，N. S. Copeland’s Cure：Homeopathy and the War between Conventional and Alternative Medicine. New York：Knopf，2005. ［134］Rose，A.，G. Oladosu，and S. Liao. “Business Interruption Impacts of a Terrorist Attack on the Electric Power System of Los Angeles：Customer Resilience to a Total Blackout”. Risk Analysis 27，no.3 （2009）：513-31. ［135］Rosenow，E. “Prophylactic Inoculation against Respiratory Infections”. JAMA 72，no.1 （1919）：31-34 ［136］Ross，R. S. “A Parlous State of Storm and Stress. The Life and Times of James B.Herrick”. Circulation 67，no.5 （1983）：955-59. ［137］Saketkhoo，K.，A. Januszkiewicz，and M. A. Sackner. “Effects of Drinking Hot Water，Cold Water，and Chicken Soup on Nasal Mucus Velocity and NasalAirflow Resistance”. Chest 74，no.4 （1978）：408-10. ［138］Saunders-Hastings，P. R.，and D. Krewski. “Reviewing the History of Pandemic Influenza：Understanding Patterns of Emergence and Transmission”. Pathogens 5，no.4 （2016）：66. ［139］Sencer，D. J.，and J. D. Millar. “Reflections on the 1976 Swine Flu Vaccination Program”. Emerging Infectious Diseases 12，no.1 （2006）：29-33. ［140］Shadrin，A. S.，I. G. Marinich，and L. Y. Taros. “Experimental and Epidemiological Estimation of Seasonal and Climato-Geographical Features of Non-Specific Resistance of the Organism to Influenza”. Journal of Hygiene，Epidemiology，Microbiology，and Immunology 21，no.2 （1977）：155-61. ［141］Shaman，J.，and A. Karspeck. “Forecasting Seasonal Outbreaks of Influenza”. Proceedings of the National Academy of Sciences 109，no.50 （2012）：20425-30. ［142］Shaman，J.，A. Karspeck，W. Yang，J. Tamerius，and M. Lipsitch. “Real-Time Influenza Forecasts during the 2012-2013 Season”. Nature Communications 4 （2013）：2837. ［143］Shanks，G. D.，S. Burroughs，J. D. Sohn，N. C. Waters，V. F. Smith，M. Waller，and J. F. Brundage. “Variable Mortality from the 1918-1919 Influenza Pandemic during Military Training”. Military Medicine 181，no.8 （2016）：878-82. ［144］Sherertz，R. J.，and H. J. Sherertz. “Influenza in the Preantibiotic Era”. Infectious Diseases in Clinical Practice 14，no.3 （2006）：127. ［145］Shortridge，K. F. “The 1918 ‘Spanish’ Flu：Pearls from Swine？” Nature Medicine 5，no.4 （1999）：384-85. ［146］Shrestha，S. S.，D. L. Swerdlow，R. H. Borse，V. S. Prabhu，L. Finelli，C. Y. Atkins，K. Owusu-Edusei et al. “Estimating the Burden of 2009 Pandemic Influenza A （H1N1）in the United States （April 2009-April 2010）”. Clinical Infectious Diseases 52，suppl.1 （2011）：S75-82. ［147］Shufflebotham，F. “Influenza among Poison Gas Workers”. British Medical Journal 1，no.3042 （1919）：478-79. ［148］Skowronski，D. M.，C. Chambers，G. De Serres，J. A. Dickinson，A. L. Winter，R. Hickman，T. Chan et al. “Early Season Co-circulation of Influenza A （H3N2）and B （Yamagata）：Interim Estimates of 2017/18 Vaccine Effectiveness，Canada，January 2018”. Eurosurveillance 23，no.5 （2018）：DOI：10.3201/eid1201.051254. ［149］Smith，D. C. “Quinine and Fever：The Development of the Effective Dosage”. Journal of the History of Medicine and Allied Sciences 31，no.3 （1976）：343-67. ［150］Smith，D. W.，and B. S. Bradshaw. “Variation in Life Expectancy during the Twentieth Century in the United States”. Demography 43，no.4 （2006）：647-57. ［151］Smith，W.，C. Andrewes，and P. Laidlaw. “A Virus Obtained from Influenza Patients”. Lancet 2，no.5723 （1933）：66-68. ［152］Sneader，W. Drug Discovery：A History. Hoboken，NJ：Wiley & Sons，2005. ［153］Sorbello，A.，S. C. Jones，W. Carter，K. Struble，R. Boucher，M. Truffa，D. Birnkrant et al. “Emergency Use Authorization for Intravenous Peramivir：Evaluation of Safety in the Treatment of Hospitalized Patients Infected with 2009 H1N1 Influenza A Virus”. Clinical Infectious Diseases 55，no.1 （2012）：1-7. ［154］Spurgeon，D. “Roche Canada Stops Distributing Oseltamivir”. British Medical Journal 331，no.7524 （2005）：1041. ［155］Starko，K. M. “Salicylates and Pandemic Influenza Mortality，1918-1919：Pharmacology，Pathology，and Historic Evidence”. Clinical Infectious Diseases 49，no.9 （2009）：1405-10. ［156］Stern，H. Theory and Practice of Bloodletting. New York：Rebman Company，1915. ［157］Stoecker，C.，N. Sanders，and A. Barreca. “Success Is Something to Sneeze At：Influenza Mortality in Regions That Send Teams to the Super Bowl”. Tulane Economics Working Paper Series 2015；Working Paper 1501. ［158］Sydenstricker，E. “The Incidence of Influenza among Persons of Different Economic Status during the Epidemic of 1918”. Public Health Reports 46，no.4 （1931）：154-70. ［159］Taubenberger，J. K. “The Origin and Virulence of the 1918 ‘Spanish’ InfluenzaVirus”. Proceedings of the American Philosophical Society 150，no.1 （2006）：86-112. ［160］Taubenberger，J. K.，J. V. Hultin，and D. M. Morens. “Discovery and Characterization of the 1918 Pandemic Influenza Virus in Historical Context”. Antiviral Therapy 12，no.4，part B （2007）：581-91. ［161］Taubenberger，J. K.，A. H. Reid，and T. G. Fanning. “Capturing a Killer Flu Virus.” Scientific American 292，no.1 （January 2005）：62-71. ［162］Taubenberger，J. K.，A. H. Reid，A. E. Krafft，K. E. Bijwaard，and T. G. Fanning. “Initial Genetic Characterization of the 1918 ‘Spanish’ Influenza Virus”. Science 275，no.5307 （1997）：1793-96. ［163］Taubenberger，J. K.，A. H. Reid，R. M. Lourens，R. Wang，G. Jin，and T. G. Fanning. “Characterization of the 1918 Influenza Virus Polymerase Genes”. Nature 437，no.7060 （2005）：889-93. ［164］Thompson，W. W.，D. K. Shay，E. Weintraub，L. Brammer，N. Cox，L. J. Anderson，and K. Fukuda. “Mortality Associated with Influenza and Respiratory Syncytial Virus in the United States”. JAMA 289，no.2 （2003）：179-86. ［165］Tiwari，Y.，S. Goel，and A. Singh. “Arrival Time Pattern and Waiting Time Distribution of Patients in the Emergency Outpatient Department of a Tertiary Level Health Care Institution of North India”. Journal of Emergencies，Trauma，and Shock 7，no.3 （2014）：160-65. ［166］Tumpey，T. M.，C. F. Basler，P. V. Aguilar，H. Zeng，A. Solorzano，D. E. Swayne，N. J. Cox et al. “Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus”. Science 310，no.5745 （2005）：77-80. ［167］“Undetermined Disease—Valencia”. Public Health Reports 33，no.26 （1918）：1087. ［168］Urashima，M.，T. Segawa，M. Okazaki，M. Kurihara，Y. Wada，and H. Ida. “Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren”. American Journal of Clinical Nutrition 91，no.5 （2010）：1255-60. ［169］Valdivia，A.，J. Lopez-Alcalde，M. Vicente，M. Pichiule，M. Ruiz，and M. Ordobas. “Monitoring Influenza Activity in Europe with Google Flu Trends：Comparison with the Findings of Sentinel Physician Networks—Results for 2009-10”. Eurosurveillance 15，no.29 （2010）：ii：19621. ［170］Vaughan，V. C. Doctor’s Memories. New York：Bobbs-Merrill Company，1926. ［171］Von Alvensleben，A. “Influenza According to Hoyle”. Nature 344，no.6265 （1990）：374. ［172］Watanabe，T.，G. Zhong，C. A. Russell，N. Nakajima，M. Hatta，A. Hanson，R.McBride，et al. “Circulating Avian Influenza Viruses Closely Related to the 1918 Virus Have Pandemic Potential”. Cell Host & Microbe 15，no.6 （2014）：692-705. ［173］Welch，S. J.，S. S. Jones，and T. Allen. “Mapping the 24-Hour Emergency Department Cycle to Improve Patient Flow”. Joint Commission Journal on Qualityand Patient Safety 33，no.5 （2007）：247-55. ［174］Welsch，R. A Treasury of Nebraska Pioneer Folklore. Lincoln：University of Nebraska Press，1967. ［175］Winternitz，M. C.，I. M. Wason，and F. P. McNamara. The Pathology of Influenza. New Haven，CT：Yale University Press，1920. ［176］Wootton，D. Bad Medicine：Doctors Doing Harm since Hippocrates. Oxford：Oxford University Press，2006. ［177］Yamanouchi，T.，K. Sakakami，and S. Iwashima. “The Infecting Agent in Influenza：An Experimental Research”. Lancet 193，no.4997 （1919）：971. ［178］Yang，Y.，A. V. Diez Roux，and C. R. Bingham. “Variability and Seasonality of Active Transportation in USA：Evidence from the 2001 NHTS”. International Journal of Behavioral Nutrition and Physical Activity 8 （2011）：96. ［179］Zadshir，A.，N. Tareen，D. Pan，K. Norris，and D. Martins. “The Prevalence of Hypovitaminosis D among U.S. Adults：Data from the NHANES III”. Ethnicity & Disease 15，no.4，suppl.5 （2005）：S5-97-101. ［180］Zhang，X.，M. I. Meltzer，and P. M. Wortley. “FluSurge——a Tool to Estimate Demand for Hospital Services during the Next Pandemic Influenza”. Medical Decision Making 26，no.6 （2006）：617-23. ［181］Abhimanyu and A. K. Coussens. “The Role of UV Radiation and Vitamin D in the Seasonality and Outcomes of Infectious Disease”. Photochemical and Photobiological Sciences 16，no.3 （2017）：314-38. ［182］Adams，F. The Genuine Works of Hippocrates. New York：William Wood，1886. ［183］Aimone，F. “The 1918 Influenza Epidemic in New York City：A Review of the Public Health Response”. Public Health Reports 125，suppl.3 （2010）：71-79. ［184］Almond，D. “Is the 1918 Influenza Pandemic Over？Long-Term Effects of InUtero Influenza Exposure in the Post-1940 U.S. Population”. Journal of Political Economy 114，no.41 （2006）：672-712. ［185］Andrews，C. The Common Cold. New York：W. W. Norton，1965. ［186］Barry，J. M. The Great Influenza：The Epic Story of the Deadliest Plague in History. New York：Penguin，2005. ［187］Barry，J. M. “The Site of Origin of the 1918 Influenza Pandemic and Its Public Health Implications”. Journal of Translational Medicine 2，no.1 （2004）：3. ［188］Bergman，P.，A. U. Lindh，L. Bjorkhem-Bergman，and J. D. Lindh. “Vitamin Dand Respiratory Tract Infections：A Systematic Review and Meta-analysis of Randomized Controlled Trials”. PLoS One 8，no.6 （2013）：e65835. ［189］Blair，G. The Trumps：Three Generations That Built an Empire. New York：Touchstone，2000. ［190］Boland，M. E.，S. M. Roper，and J. A. Henry. “Complications of Quinine Poisoning”. Lancet 325，no.8425 （1985）：384-85. ［191］Brett，A. S.，and A. Zuger.，“The Run on Tamiflu—Should Physicians Prescribeon Demand？” New England Journal of Medicine 353，no.25 （2005）：2636-37. ［192］Bridges，C. B.，W. W. Thompson，M. I. Meltzer，G. R. Reeve，W. J. Talamonti，N. J. Cox，H. A. Lilac，H. Hall，A. Klimov，and K. Fukuda. “Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults：A Randomized Controlled Trial”. JAMA 284，no.13 （2000）：1655-63. ［193］Brownstein，J. S.，C. J. Wolfe，and K. D. Mandl.，“Empirical Evidence for the Effect of Airline Travel on Inter-regional Influenza Spread in the United States”. PLoS Medicine 3，no.10 （2006）：e401. ［194］Butler，D.，“When Google Got Flu Wrong”. Nature 494，no.7436 （2013）：155-56. ［195］Byerly，C.，Fever of War：The Influenza Epidemic in the U.S. Army during WorldWar I. New York：New York University Press，2005. ［196］Cannell，J. J.，R. Vieth，J. C. Umhau，M. F. Holick，W. B. Grant，S. Madronich，C. F.，Garland，and E. Giovannucci. “Epidemic Influenza and Vitamin D”. Epidemiology & Infection 134，no.6 （2006）：1129-40. ［197］Cello，J.，A. V. Paul，and E. Wimmer. “Chemical Synthesis of Poliovirus cDNA：Generation of Infectious Virus in the Absence of Natural Template”. Science297，no.5583 （2002）：1016-18. ［198］Centers for Disease Control and Prevention. “Update：Drug Susceptibility of Swine-Origin Influenza A （H1N1）Viruses，April 2009”. Morbidity and Mortality Weekly Report 58，no.16 （2009）：433-35. ［199］Chartrand，C.，M. M. Leeflang，J. Minion，T. Brewer，and M. Pai. “Accuracy of Rapid Influenza Diagnostic Tests：A Meta-analysis”. Annals of Internal Medicine 156，no.7 （2006）：500-11. ［200］Collier，R. The Plague of the Spanish Lady：The Influenza Pandemic of 1918-1919. London：Macmillan，1974. ［201］Cook，S.，C. Conrad，A. L. Fowlkes，and M. H. Mohebbi. “Assessing Google FluTrends Performance in the United States during the 2009 Influenza Virus A （H1N1）Pandemic”. PLoS One 6，no.8 （2011）：e23610. ［202］Cooper Cole，C. E. “Preliminary Report on Influenza Epidemic at Bramshott inSeptember-October，1918”. British Medical Journal 2，no.3021 （1918）：566-68. ［203］Creighton，C. A History of Epidemics in Britain. New York：Barnes & Noble，1965. ［204］Crosby，A. W. America’s Forgotten Pandemic：The Influenza of 1918. Cambridge：Cambridge University Press，2003. ［205］Das，D.，K. Mertzger，R. Heffernan，S. Balter，D. Weiss，and F. Mostashari. “Monitoring Over-the-Counter Medication Sales for Early Detection of Disease Outbreaks—New York City”. MMWR Supplements 54 （2005）：41-46. ［206］Debauche，L. Reel Patriotism：The Movies and World War I. Madison：Universityof Wisconsin Press，1997. ［207］Demicheli，V.，T. Jefferson，L. A. Al-Ansary，E. Ferroni，and C. Di Pietrantonj. “Vaccines for Preventing Influenza in Healthy Adults”. Cochrane Database of Systematic Reviews 3 （2014）：CD001269. ［208］Dobson，J.，R. J. Whitley，S. Pocock，and A. S. Monto. “Oseltamivir Treatment for Influenza in Adults：A Meta-analysis of Randomised Controlled Trials”. Lancet 385，no.9979 （2015）：1729-37. ［209］Doshi，P. “The Elusive Definition of Pandemic Influenza”. Bulletin of the World Health Organization 89 no.7 （2011）：532-38. ［210］Doshi，P. “The 2009 Influenza Pandemic”. Lancet Infectious Diseases 13，no.3 （2013）：193. ［211］Dow，K.，and S. Cutter. “Crying Wolf：Repeat Responses to Hurricane EvacuationOrders”. Coastal Management 26，no.4 （1998）：237-52. ［212］Duncan，K. Hunting the 1918 Flu：One Scientist’s Search for a Killer Virus. Toronto：University of Toronto Press，2003. ［213］Earn，D. J.，P. W. Andrews，and B. M. Bolker. “Population-Level Effects of Suppressing Fever”. Proceedings of the Royal Society B：Biological Sciences 281，no.1778 （2014）：20132570. ［214］Edmond，J. D.，R. G. Johnston，D. Kidd，H. J. Rylance，and R. G. Sommerville. “The Inhibition of Neuraminidase and Antiviral Action”. British Journal of Pharmacology and Chemotherapy 27，no.2 （1966）：415-26. ［215］Emerman，M.，and H. S. Malik. “Paleovirology—Modern Consequences of AncientViruses”. PLoS Biology 8，no.2 （2010）：e1000301. ［216］Emerman，M.，and H. S. Malik. “The Epidemic of Influenza”. JAMA 71，no.13 （1918）：1063-64. ［217］Evans，S. S.，E. A. Repasky，and D. T. Fisher. “Fever and the Thermal Regulation of Immunity：The Immune System Feels the Heat”. Nature Reviews Immunology 15，no.6 （2015）：335-49. ［218］Eyler，J. M. “The State of Science，Microbiology，and Vaccines circa 1918”. Public Health Reports 125，suppl.3 （2010）：27-36. ［219］Fabier，F. “Traitement de la Grippe par les Injections de Quinine”. Journal de Médecineet de Chirurgie Pratiques 90 （1919）：783-84. ［220］Fiore，A. E.，T. M. Uyeki，K. Broder，L. Finelli，G. L. Euler，J. A. Singleton，J. K. Iskander et al. “Prevention and Control of Influenza with Vaccines：Recommendations of the Advisory Committee on Immunization Practices （ACIP），2010”. MMWR Recommendations and Reports 59，no. RR-8 （2010）：1-62. ［221］Garrett，T. “Pandemic Economics：The 1918 Influenza and Its Modern-Day Implications”. Federal Reserve Bank of St. Louis Review 90，no.2 （2008）：75-93. ［222］Garrett，T. “War and Pestilence as Labor Market Shocks：U.S. Manufacturing WageGrowth 1914-1919”. Economic Inquiry 47，no.4 （2009）：711-25. ［223］Gaydos，J. C.，F. H. Top Jr.，R. A. Hodder，and P. K. Russell. “Swine Influenza AOutbreak，Fort Dix，New Jersey，1976”. Emerging Infectious Diseases 12，no.1 （2006）：23-28. ［224］Gerdil，C. “The Annual Production Cycle for Influenza Vaccine”. Vaccine 21，no.16 （2003）：1776-79. ［225］Glatstein，M.，and D. Scolnik. “Fever：To Treat or Not to Treat？” World Journal of Pediatrics 4，no.4 （2008）：245-47. ［226］Godlee，F. “Conflicts of Interest and Pandemic Flu”. British Medical Journal 340 （2010）：c2947. ［227］Gregor，A. “A Note on the Epidemiology of Influenza among Workers”. British Medical Journal 1，no.3035 （1919）：242-43. ［228］Grijalva，C. G.，J. P. Nuorti，and M. R. Griffin. “Antibiotic Prescription Rates for Acute Respiratory Tract Infections in U.S. Ambulatory Settings”. JAMA 302，no.7 （2009）：758-66. ［229］Grist，N. R. “Pandemic Influenza 1918”. British Medical Journal 2，no.6205 （1979）：1632-33. ［230］Gross，C. P.，and K. A. Sepkowitz. “The Myth of the Medical Break through：Small pox，Vaccination，and Jenner Reconsidered”. International Journal of Infectious Disease 3，no.1 （1998）：54-60. ［231］Hammond，G. W.，R. L. Raddatz，and D. E. Gelskey. “Impact of Atmospheric Dispersionand Transport of Viral Aerosols on the Epidemiology of Influenza”. Reviews of Infectious Diseases 11，no.3 （1989）：494-97. ［232］Hammond，J. A. B.，W. Rolland，and T. H. G. Shore. “Purulent Bronchitis：A Studyof Cases Occurring amongst the British Troops at a Base in France”. Lancet 190，no.4898 （1917）：41-45. ［233］Hannoun，C. “The Evolving History of Influenza Viruses and Influenza Vaccines”. Expert Review of Vaccines 12，no.9 （2013）：1085-94. ［234］Hawkes，N. “Sharp Spike in Deaths in England and Wales Needs Investigating，Says Public Health Expert”. British Medical Journal 352 （2016）：i981. ［235］Hayden，F. G.，J. J. Treanor，R. F. Betts，M. Lobo，J. D. Esinhart，and E. K. Hussey. “Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza”. JAMA 275，no.4 （1996）：295-99. ［236］Henderson，D. A.，B. Courtney，T. V. Inglesby，E. Toner，and J. B. Nuzzo. “Public Health and Medical Responses to the 1957-58 Influenza Pandemic”. Biosecurityand Bioterrorism 7，no.3 （2009）：265-73. ［237］Herfst，S.，E. J. Schrauwen，M. Linster，S. Chutinimitkul，E. De Wit，V. J. Munster，E. M. Sorrell et al. “Airborne Transmission of Influenza A/H5N1 Virus between Ferrets”. Science 336，no.6088 （2012）：1534-41. ［238］Hernan，M. A.，and M. Lipsitch. “Oseltamivir and Risk of Lower RespiratoryTract Complications in Patients with Flu Symptoms：A Meta-analysis of Eleven Randomized Clinical Trials”. Clinical Infectious Diseases 53，no.3 （2011）：277-79. ［239］Herrick，J. B. “Treatment of Influenza by Means Other Than Vaccines and Serums”. JAMA 73，no.7 （1919）：482-87. ［240］Hiam，L.，D. Dorling，D. Harrison，and M. McKee. “What Caused the Spike in Mortality in England and Wales in January 2015？” Journal of the Royal Society of Medicine 110，no.4 （2017）：131-37. ［241］Hildreth，M. L. “The Influenza Epidemic of 1918-1919 in France：Contemporary Concepts of Aetiology，Therapy，and Prevention”. Social History of Medicine 4，no.2 （1991）：277-94. ［242］Hirani，V.，and P. Primatesta. “Vitamin D Concentrations among People Aged 65 Years and Over Living in Private Households and Institutions in England：Population Survey”. Age and Ageing 34 no.5 （2006）：485-91. ［243］Hirve，S.，L. P. Newman，J. Paget，E. Azziz-Baumgartner，J. Fitzner，N. Bhat，K. Vandemaele，and W. Zhang. “Influenza Seasonality in the Tropics and Subtropics—When to Vaccinate？” PLoS One 11，no.4 （2016）：e0153003. ［244］Honigsbaum，M. “Regulating the 1918-19 Pandemic：Flu，Stoicism and theNorthcliffe Press”. Medical History 57，no.2 （2013）：165-85. ［245］Hopkirk，A. F. Influenza：Its History，Nature，Cause and Treatment. New York：Walter Scott Publishing，1914. ［246］Hoyle，F.，and C. Wickramasinghe. Evolution from Space：A Theory of Cosmic Creationism.New York：Simon & Schuster，1982. ［247］Hoyle，F.，and N. C. Wickramasinghe. “Sunspots and Influenza”. Nature 343，no.6256 （1990）：304. ［248］Hughes，S. S. The Virus：A History of the Concept. London：Heinemann Educational Books，Science History Publications，1977. ［249］Influenza Committee of the Advisory Board to the D.G.M.S.，France. “The Influenza Epidemic in the British Armies in France，1918”. British Medical Journal 2，no.3019 （1918）：505-9. ［250］“Influenza Discussions”. American Journal of Public Health 9，no.2 （1919）：136. ［251］“Influenza：Its History，Nature，Cause and Treatment”. Book review. JAMA 63，no.3 （1914）：267. ［252］“Influenza：Kansas—Haskell”. Public Health Reports 33，no.14 （1918）：502. ［253］Jack，A. “Flu’s Unexpected Bonus”. British Medical Journal 339 （2009）：b3811. “James B. Herrick （1861-1954）”. JAMA 16，no.186 （1963）：722-23. ［254］Jefferson，T. “Influenza Vaccination：Policy versus Evidence”. British Medical Journal 333，no.7574 （2006）：912-15. ［255］Jefferson，T.，V. Demicheli，D. Rivetti，M. Jones，C. Di Pietrantonj，and A. Rivetti. “Antivirals for Influenza in Healthy Adults：Systematic Review”. Lancet 367，no.9507 （2006）：303-13. ［256］Jefferson，T.，and P. Doshi. “Multisystem Failure：The Story of Anti-influenza Drugs”. British Medical Journal 348 （2014）：g2263. ［257］Jefferson，T.，M. A. Jones，P. Doshi，C. B. Del Mar，R. Hama，M. J. Thompson，E. A. Spencer et al. “Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children”. Cochrane Database of Systematic Reviews 4 （2014）：CD008965. ［258］Jenner，E. An Inquiry into the Causes and Effects of the VariolaeVaccinae，a Disease Discovered in Some of the Western Counties of England，Particularly Gloucestershire，and Known by the Name of the Cow Pox. London：Sampson Low，1798. ［259］Kaiser，L.，C. Wat，T. Mills，P. Mahoney，P. Ward，and F. Hayden. “Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complicationsand Hospitalizations”. Archives of Internal Medicine 163，no.14 （2003）：1667-72. ［260］Kamat，S.，V. Maniaci，M. Y. Linares，and J. M. Lozano. “Pediatric Psychiatric Emergency Department Visits during a Full Moon.” Pediatric Emergency Care 30，no.12 （2014）：875-78. ［261］Kelly，H.，and K. Grant. “Interim Analysis of Pandemic Influenza （H1N1）2009 in Australia：Surveillance Trends，Age of Infection and Effectiveness of SeasonalVaccination”. Eurosurveillance 14，no.31 （2009）：1-5. ［262］Kennedy，D. “Better Never Than Late”. Science 310，no.5746 （2005）：195. ［263］Khan，A.，and W. Patrick. The Next Pandemic：On the Front Lines against Humankind’s Gravest Dangers. New York：Public Affairs，2016. ［264］Kilbourne，E. D. “Influenza Pandemics of the 20th Century”. Emerging Infectious Diseases 12，no.1 （2006）：9-14. ［265］Klein，H. A. “The Treatment of ‘Spanish Influenza’”. JAMA 71，no.18 （1918）：1510. ［266］Kluger，M. J. Fever：Its Biology，Evolution，and Function. Princeton，NJ：Princeton University Press，1979. ［267］Kmietowicz，Z. “Use Leftover Tamiflu to Grit Icy Roads，MP Suggests”. British Medical Journal 340 （2010）：c501. ［268］Kochanek，K. D.，S. L. Murphy，J. Xu，and B. Tejada-Vera. “Deaths：Final Data for 2014”. National Vital Statistics Reports 65，no.4 （2016）：1-122. ［269］Kolata，G. Flu：The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It. New York：Touchstone，2005. ［270］Lamb，F.，and E. Brannin. “The Epidemic Respiratory Infection at Camp Cody N.M”. JAMA 72，no.15 （1919）：1056-62. ［271］Langford，C. “Did the 1918-19 Influenza Pandemic Originate in China？” Populationand Development Review 31，no.3 （2005）：479-505. ［272］Langmuir，A. D.，T. D. Worthen，J. Solomon，C. G. Ray，and E. Petersen. “TheThucydides Syndrome. A New Hypothesis for the Cause of the Plague of Athens”. New England Journal of Medicine 313，no.16 （1985）：1027-30. ［273］Lazer，D.，R. Kennedy，G. King，and A. Vespignani. “The Parable of Google Flu：Traps in Big Data Analysis”. Science 343，no.6176 （2014）：1203-5. ［274］Leary，T. “The Use of the Influenza Vaccine in the Present Epidemic”. American Journal of Public Health 8，no.10 （1918）：754-55. ［275］Li，W.，S. K. Wong，F. Li，J. H. Kuhn，I. C. Huang，H. Choe，and M. Farzan. “Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus：Insight from ACE2-S-Protein Interactions”. Journal of Virology 80，no.9 （2006）：4211-19. ［276］Linder，J. A. “Vitamin D and the Cure for the Common Cold”. JAMA 308，no.13 （2012）：1375-76. ［277］Lowen，A. C.，S. Mubareka，J. Steel，and P. Palese. “Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature”. PLoS Pathogens 3，no.10 （2007）：1470-76. ［278］Malik，M. T.，A. Gumel，L. H. Thompson，T. Strome，and S. M. Mahmud. “‘Google Flu Trends’ and Emergency Department Triage Data Predicted the 2009 Pandemic H1N1 Waves in Manitoba”. Canadian Journal of Public Health 102，no.4 （2011）：294-97. ［279］Mamelund，S. E. “A Socially Neutral Disease？Individual Social Class，Household Wealth and Mortality from Spanish Influenza in Two Socially ContrastingParishes in Kristiania 1918-19”. Social Science & Medicine 62，no.4 （2006）：923-40. ［280］McCarthy，M. L.，S. L. Zeger，R. Ding，D. Aronsky，N. R. Hoot，and G. D. Kelen. “The Challenge of Predicting Demand for Emergency Department Services”. Academic Emergency Medicine 15，no.4 （2008）：337-46. ［281］McGuire，A.，M. Drummond，and S. Keeping. “Childhood and Adolescent Influenza Vaccination in Europe：A Review of Current Policies and Recommendations for the Future”. Expert Review of Vaccines 15，no.5 （2016）：659-70. ［282］McOscar，J. “Influenza in the Lay Press”. British Medical Journal 2，no.3019 （1918）：534. ［283］Mitton，S. Fred Hoyle：A Life in Science. Cambridge：Cambridge University Press，2011. ［284］Molinari，N. A.，I. R. Ortega-Sanchez，M. L. Messonnier，W. W. Thompson，P. M.Wortley，E. Weintraub，and C. B. Bridges. “The Annual Impact of Seasonal Influenza in the U.S.：Measuring Disease Burden and Costs”. Vaccine 25，no.27 （2007）：5086-96. ［285］Morens，D. M. “Death of a President”. New England Journal of Medicine 341，no.24 （1999）：1845-49. ［286］Morens，D. M.，and A. S. Fauci. “The 1918 Influenza Pandemic：Insights for the 21st Century”. Journal of Infectious Disease 195，no.7 （2007）：1019-28. ［287］Morens，D. M.，G. K. Folkers，and A. S. Fauci. “What Is a Pandemic？” Journal of Infectious Disease 200，no.7 （2009）：1018-21. ［288］Morens，D. M.，J. K. Taubenberger，and A. S. Fauci. “The Persistent Legacy of the 1918 Influenza Virus”. New England Journal of Medicine 361，no.3 （2009）：225-29. ［289］Moscona，A. “Neuraminidase Inhibitors for Influenza”. New England Journal of Medicine 353，no.13 （2005）：1363-73. ［290］Moser，M. R.，T. R. Bender，H. S. Margolis，G. R. Noble，A. P. Kendal，and D. G.Ritter. “An Outbreak of Influenza aboard a Commercial Airliner”. American Journal of Epidemiology 110，no.1 （1979）：1-6. ［291］Murdoch，D. R.，S. Slow，S. T. Chambers，L. C. Jennings，A. W. Stewart，P. C.Priest，C. M. Florkowski，J. H. Livesey，A. C. Camargo，and R. Scragg. “Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infectionsin Healthy Adults：The Vidaris Randomized Controlled Trial”. JAMA 308，no.13 （2012）：1333-39. ［292］Murray，C. J.，A. D. Lopez，B. Chin，D. Feehan，and K. H. Hill. “Estimation of Potential Global Pandemic Influenza Mortality on the Basis of Vital Registry Data from the 1918-20 Pandemic：A Quantitative Analysis”. Lancet 368，no.9554 （2006）：2211-18. ［293］Murthy，S.，and H. Wunsch. “Clinical Review：International Comparisons in Critical Care—Lessons Learned”. Critical Care 16，no.2 （2012）：218. ［294］Nguyen，J. L.，J. Schwartz，and D. W. Dockery. “The Relationship between Indoor and Outdoor Temperature，Apparent Temperature，Relative Humidity，and Absolute Humidity”. Indoor Air 24，no.1 （2014）：103-12. ［295］Nicolson，J. The Great Silence，1918-1920：Living in the Shadow of the Great War.London：Grove Press，2010. ［296］Noti，J. D.，F. M. Blachere，C. M. McMillen，W. G. Lindsley，M. L. Kashon，D. R.Slaughter，and D. H. Beezhold. “High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs”. PLoS One 8，no.2 （2013）：e57485. ［297］Olitsky，P.，and F. Gates. “Experimental Study of the Nasopharyngeal Secretions from Influenza Patients”. JAMA 74，no.22 （1920）：1497-99. ［298］Opie，E.，A. Freeman，F. Blake，J. Small，and T. Rivers. “Pneumonia at Camp Funston”. JAMA 72，no.2 （1919）：108-13. ［299］Ortiz，J. R.，L. Kamimoto，R. E. Aubert，J. Yao，D. K. Shay，J. S. Bresee，and R. S.Epstein. “Oseltamivir Prescribing in Pharmacy-Benefits Database，United States，2004-2005”. Emerging Infectious Diseases 14，no.8 （2008）：1280-83. ［300］Oshinsky，D. M. Polio：An American Story. Oxford：Oxford University Press，2005. ［301］Oxford，J. S. “The So-Called Great Spanish Influenza Pandemic of 1918 May Have Originated in France in 1916”. Philosophical Transactions of the Royal Society of London，Series B：Biological Sciences 356，no.1416 （2001）：1857-59. ［302］Patterson，K. D. Pandemic Influenza，1700-1900. Totowa，NJ：Rowman and Littlefield，1986. ［303］Patwardhan，A.，and R. Bilkovski. “Comparison：Flu Prescription Sales Data from a Retail Pharmacy in the U.S. with Google Flu Trends and U.S. ILINet （CDC）Data as Flu Activity Indicator”. PLoS One 7，no.8 （2012）：e43611. ［304］Petersen，W. F.，and S. A. Levinson. “The Therapeutic Effect of Venesection with Reference to Lobar Pneumonia”. JAMA 78，no.4 （1922）：257-58. ［305］Polgreen，P. M.，F. D. Nelson，and G. R. Neumann. “Use of Prediction Markets to Forecast Infectious Disease Activity”. Clinical Infectious Diseases 44，no.2 （2007）：272-79. ［306］Prager，F.，D. Wei，and A. Rose. “Total Economic Consequences of an Influenza Outbreak in the United States”. Risk Analysis 37，no.1 （2017）：4-19. ［307］Price，G. M. “Influenza—Destroyer and Teacher”. Survey 41，no.12 （1918）：367-69. ［308］“Proceedings of the Forty-Sixth Annual Meeting of the American Public Health Association”. American Journal of Public Health 9，no.2 （1919）：130-42. ［309］Reichert，T. A.，N. Sugaya，D. S. Fedson，W. P. Glezen，L. Simonsen，and M. Tashiro. “The Japanese Experience with Vaccinating Schoolchildren against Influenza”. New England Journal of Medicine 344，no.12 （2001）：889-96. ［310］Reid，A. H.，T. A. Janczewski，R. M. Lourens，A. J. Elliot，R. S. Daniels，C. L. Berry，J. S. Oxford，and J. K. Taubenberger. “1918 Influenza Pandemic Caused by Highly Conserved Viruses with Two Receptor-Binding Variants”. Emerging Infectious Diseases 9，no.10 （2003）：1249-53. ［311］Rice，E. W.，N. J. Adcock，M. Sivaganesan，J. D. Brown，D. E. Stallknecht，and D. E.Swayne. “Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus （H5N1）”. Emerging Infectious Diseases 13，no.10 （2007）：1568-70. ［312］Riedel，S. “Edward Jenner and the History of Smallpox and Vaccination.” Proceedings （Baylor University Medical Center） 18，no.1 （2005）：21-25. ［313］Robins，N. S. Copeland’s Cure：Homeopathy and the War between Conventional and Alternative Medicine. New York：Knopf，2005. ［314］Rose，A.，G. Oladosu，and S. Liao. “Business Interruption Impacts of a Terrorist Attack on the Electric Power System of Los Angeles：Customer Resilience to a Total Blackout”. Risk Analysis 27，no.3 （2009）：513-31. ［315］Rosenow，E. “Prophylactic Inoculation against Respiratory Infections”. JAMA 72，no.1 （1919）：31-34 ［316］Ross，R. S. “A Parlous State of Storm and Stress. The Life and Times of James B.Herrick”. Circulation 67，no.5 （1983）：955-59. ［317］Saketkhoo，K.，A. Januszkiewicz，and M. A. Sackner. “Effects of Drinking Hot Water，Cold Water，and Chicken Soup on Nasal Mucus Velocity and NasalAirflow Resistance”. Chest 74，no.4 （1978）：408-10. ［318］Saunders-Hastings，P. R.，and D. Krewski. “Reviewing the History of Pandemic Influenza：Understanding Patterns of Emergence and Transmission”. Pathogens 5，no.4 （2016）：66. ［319］Sencer，D. J.，and J. D. Millar. “Reflections on the 1976 Swine Flu Vaccination Program”. Emerging Infectious Diseases 12，no.1 （2006）：29-33. ［320］Shadrin，A. S.，I. G. Marinich，and L. Y. Taros. “Experimental and Epidemiological Estimation of Seasonal and Climato-Geographical Features of Non-Specific Resistance of the Organism to Influenza”. Journal of Hygiene，Epidemiology，Microbiology，and Immunology 21，no.2 （1977）：155-61. ［321］Shaman，J.，and A. Karspeck. “Forecasting Seasonal Outbreaks of Influenza”. Proceedings of the National Academy of Sciences 109，no.50 （2012）：20425-30. ［322］Shaman，J.，A. Karspeck，W. Yang，J. Tamerius，and M. Lipsitch. “Real-Time Influenza Forecasts during the 2012-2013 Season”. Nature Communications 4 （2013）：2837. ［323］Shanks，G. D.，S. Burroughs，J. D. Sohn，N. C. Waters，V. F. Smith，M. Waller，and J. F. Brundage. “Variable Mortality from the 1918-1919 Influenza Pandemic during Military Training”. Military Medicine 181，no.8 （2016）：878-82. ［324］Sherertz，R. J.，and H. J. Sherertz. “Influenza in the Preantibiotic Era”. Infectious Diseases in Clinical Practice 14，no.3 （2006）：127. ［325］Shortridge，K. F. “The 1918 ‘Spanish’ Flu：Pearls from Swine？” Nature Medicine 5，no.4 （1999）：384-85. ［326］Shrestha，S. S.，D. L. Swerdlow，R. H. Borse，V. S. Prabhu，L. Finelli，C. Y. Atkins，K. Owusu-Edusei et al. “Estimating the Burden of 2009 Pandemic Influenza A （H1N1）in the United States （April 2009-April 2010）”. Clinical Infectious Diseases 52，suppl.1 （2011）：S75-82. ［327］Shufflebotham，F. “Influenza among Poison Gas Workers”. British Medical Journal 1，no.3042 （1919）：478-79. ［328］Skowronski，D. M.，C. Chambers，G. De Serres，J. A. Dickinson，A. L. Winter，R. Hickman，T. Chan et al. “Early Season Co-circulation of Influenza A （H3N2）and B （Yamagata）：Interim Estimates of 2017/18 Vaccine Effectiveness，Canada，January 2018”. Eurosurveillance 23，no.5 （2018）：DOI：10.3201/eid1201.051254. ［329］Smith，D. C. “Quinine and Fever：The Development of the Effective Dosage”. Journal of the History of Medicine and Allied Sciences 31，no.3 （1976）：343-67. ［330］Smith，D. W.，and B. S. Bradshaw. “Variation in Life Expectancy during the Twentieth Century in the United States”. Demography 43，no.4 （2006）：647-57. ［331］Smith，W.，C. Andrewes，and P. Laidlaw. “A Virus Obtained from Influenza Patients”. Lancet 2，no.5723 （1933）：66-68. ［332］Sneader，W. Drug Discovery：A History. Hoboken，NJ：Wiley & Sons，2005. ［333］Sorbello，A.，S. C. Jones，W. Carter，K. Struble，R. Boucher，M. Truffa，D. Birnkrant et al. “Emergency Use Authorization for Intravenous Peramivir：Evaluation of Safety in the Treatment of Hospitalized Patients Infected with 2009 H1N1 Influenza A Virus”. Clinical Infectious Diseases 55，no.1 （2012）：1-7. ［334］Spurgeon，D. “Roche Canada Stops Distributing Oseltamivir”. British Medical Journal 331，no.7524 （2005）：1041. ［335］Starko，K. M. “Salicylates and Pandemic Influenza Mortality，1918-1919：Pharmacology，Pathology，and Historic Evidence”. Clinical Infectious Diseases 49，no.9 （2009）：1405-10. ［336］Stern，H. Theory and Practice of Bloodletting. New York：Rebman Company，1915. ［337］Stoecker，C.，N. Sanders，and A. Barreca. “Success Is Something to Sneeze At：Influenza Mortality in Regions That Send Teams to the Super Bowl”. Tulane Economics Working Paper Series 2015；Working Paper 1501. ［338］Sydenstricker，E. “The Incidence of Influenza among Persons of Different Economic Status during the Epidemic of 1918”. Public Health Reports 46，no.4 （1931）：154-70. ［339］Taubenberger，J. K. “The Origin and Virulence of the 1918 ‘Spanish’ InfluenzaVirus”. Proceedings of the American Philosophical Society 150，no.1 （2006）：86-112. ［340］Taubenberger，J. K.，J. V. Hultin，and D. M. Morens. “Discovery and Characterization of the 1918 Pandemic Influenza Virus in Historical Context”. Antiviral Therapy 12，no.4，part B （2007）：581-91. ［341］Taubenberger，J. K.，A. H. Reid，and T. G. Fanning. “Capturing a Killer Flu Virus.” Scientific American 292，no.1 （January 2005）：62-71. ［342］Taubenberger，J. K.，A. H. Reid，A. E. Krafft，K. E. Bijwaard，and T. G. Fanning. “Initial Genetic Characterization of the 1918 ‘Spanish’ Influenza Virus”. Science 275，no.5307 （1997）：1793-96. ［343］Taubenberger，J. K.，A. H. Reid，R. M. Lourens，R. Wang，G. Jin，and T. G. Fanning. “Characterization of the 1918 Influenza Virus Polymerase Genes”. Nature 437，no.7060 （2005）：889-93. ［344］Thompson，W. W.，D. K. Shay，E. Weintraub，L. Brammer，N. Cox，L. J. Anderson，and K. Fukuda. “Mortality Associated with Influenza and Respiratory Syncytial Virus in the United States”. JAMA 289，no.2 （2003）：179-86. ［345］Tiwari，Y.，S. Goel，and A. Singh. “Arrival Time Pattern and Waiting Time Distribution of Patients in the Emergency Outpatient Department of a Tertiary Level Health Care Institution of North India”. Journal of Emergencies，Trauma，and Shock 7，no.3 （2014）：160-65. ［346］Tumpey，T. M.，C. F. Basler，P. V. Aguilar，H. Zeng，A. Solorzano，D. E. Swayne，N. J. Cox et al. “Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus”. Science 310，no.5745 （2005）：77-80. ［347］“Undetermined Disease—Valencia”. Public Health Reports 33，no.26 （1918）：1087. ［348］Urashima，M.，T. Segawa，M. Okazaki，M. Kurihara，Y. Wada，and H. Ida. “Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren”. American Journal of Clinical Nutrition 91，no.5 （2010）：1255-60. ［349］Valdivia，A.，J. Lopez-Alcalde，M. Vicente，M. Pichiule，M. Ruiz，and M. Ordobas. “Monitoring Influenza Activity in Europe with Google Flu Trends：Comparison with the Findings of Sentinel Physician Networks—Results for 2009-10”. Eurosurveillance 15，no.29 （2010）：ii：19621. ［350］Vaughan，V. C. Doctor’s Memories. New York：Bobbs-Merrill Company，1926. ［351］Von Alvensleben，A. “Influenza According to Hoyle”. Nature 344，no.6265 （1990）：374. ［352］Watanabe，T.，G. Zhong，C. A. Russell，N. Nakajima，M. Hatta，A. Hanson，R.McBride，et al. “Circulating Avian Influenza Viruses Closely Related to the 1918 Virus Have Pandemic Potential”. Cell Host & Microbe 15，no.6 （2014）：692-705. ［353］Welch，S. J.，S. S. Jones，and T. Allen. “Mapping the 24-Hour Emergency Department Cycle to Improve Patient Flow”. Joint Commission Journal on Qualityand Patient Safety 33，no.5 （2007）：247-55. ［354］Welsch，R. A Treasury of Nebraska Pioneer Folklore. Lincoln：University of Nebraska Press，1967. ［355］Winternitz，M. C.，I. M. Wason，and F. P. McNamara. The Pathology of Influenza. New Haven，CT：Yale University Press，1920. ［356］Wootton，D. Bad Medicine：Doctors Doing Harm since Hippocrates. Oxford：Oxford University Press，2006. ［357］Yamanouchi，T.，K. Sakakami，and S. Iwashima. “The Infecting Agent in Influenza：An Experimental Research”. Lancet 193，no.4997 （1919）：971. ［358］Yang，Y.，A. V. Diez Roux，and C. R. Bingham. “Variability and Seasonality of Active Transportation in USA：Evidence from the 2001 NHTS”. International Journal of Behavioral Nutrition and Physical Activity 8 （2011）：96. ［359］Zadshir，A.，N. Tareen，D. Pan，K. Norris，and D. Martins. “The Prevalence of Hypovitaminosis D among U.S. Adults：Data from the NHANES III”. Ethnicity & Disease 15，no.4，suppl.5 （2005）：S5-97-101. ［360］Zhang，X.，M. I. Meltzer，and P. M. Wortley. “FluSurge——a Tool to Estimate Demand for Hospital Services during the Next Pandemic Influenza”. Medical Decision Making 26，no.6 （2006）：617-23. ［361］Abhimanyu and A. K. Coussens. “The Role of UV Radiation and Vitamin D in the Seasonality and Outcomes of Infectious Disease”. Photochemical and Photobiological Sciences 16，no.3 （2017）：314-38. ［362］Adams，F. The Genuine Works of Hippocrates. New York：William Wood，1886. ［363］Aimone，F. “The 1918 Influenza Epidemic in New York City：A Review of the Public Health Response”. Public Health Reports 125，suppl.3 （2010）：71-79. ［364］Almond，D. “Is the 1918 Influenza Pandemic Over？Long-Term Effects of InUtero Influenza Exposure in the Post-1940 U.S. Population”. Journal of Political Economy 114，no.41 （2006）：672-712. ［365］Andrews，C. The Common Cold. New York：W. W. Norton，1965. ［366］Barry，J. M. The Great Influenza：The Epic Story of the Deadliest Plague in History. New York：Penguin，2005. ［367］Barry，J. M. “The Site of Origin of the 1918 Influenza Pandemic and Its Public Health Implications”. Journal of Translational Medicine 2，no.1 （2004）：3. ［368］Bergman，P.，A. U. Lindh，L. Bjorkhem-Bergman，and J. D. Lindh. “Vitamin Dand Respiratory Tract Infections：A Systematic Review and Meta-analysis of Randomized Controlled Trials”. PLoS One 8，no.6 （2013）：e65835. ［369］Blair，G. The Trumps：Three Generations That Built an Empire. New York：Touchstone，2000. ［370］Boland，M. E.，S. M. Roper，and J. A. Henry. “Complications of Quinine Poisoning”. Lancet 325，no.8425 （1985）：384-85. ［371］Brett，A. S.，and A. Zuger.，“The Run on Tamiflu—Should Physicians Prescribeon Demand？” New England Journal of Medicine 353，no.25 （2005）：2636-37. ［372］Bridges，C. B.，W. W. Thompson，M. I. Meltzer，G. R. Reeve，W. J. Talamonti，N. J. Cox，H. A. Lilac，H. Hall，A. Klimov，and K. Fukuda. “Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults：A Randomized Controlled Trial”. JAMA 284，no.13 （2000）：1655-63. ［373］Brownstein，J. S.，C. J. Wolfe，and K. D. Mandl.，“Empirical Evidence for the Effect of Airline Travel on Inter-regional Influenza Spread in the United States”. PLoS Medicine 3，no.10 （2006）：e401. ［374］Butler，D.，“When Google Got Flu Wrong”. Nature 494，no.7436 （2013）：155-56. ［375］Byerly，C.，Fever of War：The Influenza Epidemic in the U.S. Army during WorldWar I. New York：New York University Press，2005. ［376］Cannell，J. J.，R. Vieth，J. C. Umhau，M. F. Holick，W. B. Grant，S. Madronich，C. F.，Garland，and E. Giovannucci. “Epidemic Influenza and Vitamin D”. Epidemiology & Infection 134，no.6 （2006）：1129-40. ［377］Cello，J.，A. V. Paul，and E. Wimmer. “Chemical Synthesis of Poliovirus cDNA：Generation of Infectious Virus in the Absence of Natural Template”. Science297，no.5583 （2002）：1016-18. ［378］Centers for Disease Control and Prevention. “Update：Drug Susceptibility of Swine-Origin Influenza A （H1N1）Viruses，April 2009”. Morbidity and Mortality Weekly Report 58，no.16 （2009）：433-35. ［379］Chartrand，C.，M. M. Leeflang，J. Minion，T. Brewer，and M. Pai. “Accuracy of Rapid Influenza Diagnostic Tests：A Meta-analysis”. Annals of Internal Medicine 156，no.7 （2006）：500-11. ［380］Collier，R. The Plague of the Spanish Lady：The Influenza Pandemic of 1918-1919. London：Macmillan，1974. ［381］Cook，S.，C. Conrad，A. L. Fowlkes，and M. H. Mohebbi. “Assessing Google FluTrends Performance in the United States during the 2009 Influenza Virus A （H1N1）Pandemic”. PLoS One 6，no.8 （2011）：e23610. ［382］Cooper Cole，C. E. “Preliminary Report on Influenza Epidemic at Bramshott inSeptember-October，1918”. British Medical Journal 2，no.3021 （1918）：566-68. ［383］Creighton，C. A History of Epidemics in Britain. New York：Barnes & Noble，1965. ［384］Crosby，A. W. America’s Forgotten Pandemic：The Influenza of 1918. Cambridge：Cambridge University Press，2003. ［385］Das，D.，K. Mertzger，R. Heffernan，S. Balter，D. Weiss，and F. Mostashari. “Monitoring Over-the-Counter Medication Sales for Early Detection of Disease Outbreaks—New York City”. MMWR Supplements 54 （2005）：41-46. ［386］Debauche，L. Reel Patriotism：The Movies and World War I. Madison：Universityof Wisconsin Press，1997. ［387］Demicheli，V.，T. Jefferson，L. A. Al-Ansary，E. Ferroni，and C. Di Pietrantonj. “Vaccines for Preventing Influenza in Healthy Adults”. Cochrane Database of Systematic Reviews 3 （2014）：CD001269. ［388］Dobson，J.，R. J. Whitley，S. Pocock，and A. S. Monto. “Oseltamivir Treatment for Influenza in Adults：A Meta-analysis of Randomised Controlled Trials”. Lancet 385，no.9979 （2015）：1729-37. ［389］Doshi，P. “The Elusive Definition of Pandemic Influenza”. Bulletin of the World Health Organization 89 no.7 （2011）：532-38. ［390］Doshi，P. “The 2009 Influenza Pandemic”. Lancet Infectious Diseases 13，no.3 （2013）：193. ［391］Dow，K.，and S. Cutter. “Crying Wolf：Repeat Responses to Hurricane EvacuationOrders”. Coastal Management 26，no.4 （1998）：237-52. ［392］Duncan，K. Hunting the 1918 Flu：One Scientist’s Search for a Killer Virus. Toronto：University of Toronto Press，2003. ［393］Earn，D. J.，P. W. Andrews，and B. M. Bolker. “Population-Level Effects of Suppressing Fever”. Proceedings of the Royal Society B：Biological Sciences 281，no.1778 （2014）：20132570. ［394］Edmond，J. D.，R. G. Johnston，D. Kidd，H. J. Rylance，and R. G. Sommerville. “The Inhibition of Neuraminidase and Antiviral Action”. British Journal of Pharmacology and Chemotherapy 27，no.2 （1966）：415-26. ［395］Emerman，M.，and H. S. Malik. “Paleovirology—Modern Consequences of AncientViruses”. PLoS Biology 8，no.2 （2010）：e1000301. ［396］Emerman，M.，and H. S. Malik. “The Epidemic of Influenza”. JAMA 71，no.13 （1918）：1063-64. ［397］Evans，S. S.，E. A. Repasky，and D. T. Fisher. “Fever and the Thermal Regulation of Immunity：The Immune System Feels the Heat”. Nature Reviews Immunology 15，no.6 （2015）：335-49. ［398］Eyler，J. M. “The State of Science，Microbiology，and Vaccines circa 1918”. Public Health Reports 125，suppl.3 （2010）：27-36. ［399］Fabier，F. “Traitement de la Grippe par les Injections de Quinine”. Journal de Médecineet de Chirurgie Pratiques 90 （1919）：783-84. ［400］Fiore，A. E.，T. M. Uyeki，K. Broder，L. Finelli，G. L. Euler，J. A. Singleton，J. K. Iskander et al. “Prevention and Control of Influenza with Vaccines：Recommendations of the Advisory Committee on Immunization Practices （ACIP），2010”. MMWR Recommendations and Reports 59，no. RR-8 （2010）：1-62. ［401］Garrett，T. “Pandemic Economics：The 1918 Influenza and Its Modern-Day Implications”. Federal Reserve Bank of St. Louis Review 90，no.2 （2008）：75-93. ［402］Garrett，T. “War and Pestilence as Labor Market Shocks：U.S. Manufacturing WageGrowth 1914-1919”. Economic Inquiry 47，no.4 （2009）：711-25. ［403］Gaydos，J. C.，F. H. Top Jr.，R. A. Hodder，and P. K. Russell. “Swine Influenza AOutbreak，Fort Dix，New Jersey，1976”. Emerging Infectious Diseases 12，no.1 （2006）：23-28. ［404］Gerdil，C. “The Annual Production Cycle for Influenza Vaccine”. Vaccine 21，no.16 （2003）：1776-79. ［405］Glatstein，M.，and D. Scolnik. “Fever：To Treat or Not to Treat？” World Journal of Pediatrics 4，no.4 （2008）：245-47. ［406］Godlee，F. “Conflicts of Interest and Pandemic Flu”. British Medical Journal 340 （2010）：c2947. ［407］Gregor，A. “A Note on the Epidemiology of Influenza among Workers”. British Medical Journal 1，no.3035 （1919）：242-43. ［408］Grijalva，C. G.，J. P. Nuorti，and M. R. Griffin. “Antibiotic Prescription Rates for Acute Respiratory Tract Infections in U.S. Ambulatory Settings”. JAMA 302，no.7 （2009）：758-66. ［409］Grist，N. R. “Pandemic Influenza 1918”. British Medical Journal 2，no.6205 （1979）：1632-33. ［410］Gross，C. P.，and K. A. Sepkowitz. “The Myth of the Medical Break through：Small pox，Vaccination，and Jenner Reconsidered”. International Journal of Infectious Disease 3，no.1 （1998）：54-60. ［411］Hammond，G. W.，R. L. Raddatz，and D. E. Gelskey. “Impact of Atmospheric Dispersionand Transport of Viral Aerosols on the Epidemiology of Influenza”. Reviews of Infectious Diseases 11，no.3 （1989）：494-97. ［412］Hammond，J. A. B.，W. Rolland，and T. H. G. Shore. “Purulent Bronchitis：A Studyof Cases Occurring amongst the British Troops at a Base in France”. Lancet 190，no.4898 （1917）：41-45. ［413］Hannoun，C. “The Evolving History of Influenza Viruses and Influenza Vaccines”. Expert Review of Vaccines 12，no.9 （2013）：1085-94. ［414］Hawkes，N. “Sharp Spike in Deaths in England and Wales Needs Investigating，Says Public Health Expert”. British Medical Journal 352 （2016）：i981. ［415］Hayden，F. G.，J. J. Treanor，R. F. Betts，M. Lobo，J. D. Esinhart，and E. K. Hussey. “Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza”. JAMA 275，no.4 （1996）：295-99. ［416］Henderson，D. A.，B. Courtney，T. V. Inglesby，E. Toner，and J. B. Nuzzo. “Public Health and Medical Responses to the 1957-58 Influenza Pandemic”. Biosecurityand Bioterrorism 7，no.3 （2009）：265-73. ［417］Herfst，S.，E. J. Schrauwen，M. Linster，S. Chutinimitkul，E. De Wit，V. J. Munster，E. M. Sorrell et al. “Airborne Transmission of Influenza A/H5N1 Virus between Ferrets”. Science 336，no.6088 （2012）：1534-41. ［418］Hernan，M. A.，and M. Lipsitch. “Oseltamivir and Risk of Lower RespiratoryTract Complications in Patients with Flu Symptoms：A Meta-analysis of Eleven Randomized Clinical Trials”. Clinical Infectious Diseases 53，no.3 （2011）：277-79. ［419］Herrick，J. B. “Treatment of Influenza by Means Other Than Vaccines and Serums”. JAMA 73，no.7 （1919）：482-87. ［420］Hiam，L.，D. Dorling，D. Harrison，and M. McKee. “What Caused the Spike in Mortality in England and Wales in January 2015？” Journal of the Royal Society of Medicine 110，no.4 （2017）：131-37. ［421］Hildreth，M. L. “The Influenza Epidemic of 1918-1919 in France：Contemporary Concepts of Aetiology，Therapy，and Prevention”. Social History of Medicine 4，no.2 （1991）：277-94. ［422］Hirani，V.，and P. Primatesta. “Vitamin D Concentrations among People Aged 65 Years and Over Living in Private Households and Institutions in England：Population Survey”. Age and Ageing 34 no.5 （2006）：485-91. ［423］Hirve，S.，L. P. Newman，J. Paget，E. Azziz-Baumgartner，J. Fitzner，N. Bhat，K. Vandemaele，and W. Zhang. “Influenza Seasonality in the Tropics and Subtropics—When to Vaccinate？” PLoS One 11，no.4 （2016）：e0153003. ［424］Honigsbaum，M. “Regulating the 1918-19 Pandemic：Flu，Stoicism and theNorthcliffe Press”. Medical History 57，no.2 （2013）：165-85. ［425］Hopkirk，A. F. Influenza：Its History，Nature，Cause and Treatment. New York：Walter Scott Publishing，1914. ［426］Hoyle，F.，and C. Wickramasinghe. Evolution from Space：A Theory of Cosmic Creationism.New York：Simon & Schuster，1982. ［427］Hoyle，F.，and N. C. Wickramasinghe. “Sunspots and Influenza”. Nature 343，no.6256 （1990）：304. ［428］Hughes，S. S. The Virus：A History of the Concept. London：Heinemann Educational Books，Science History Publications，1977. ［429］Influenza Committee of the Advisory Board to the D.G.M.S.，France. “The Influenza Epidemic in the British Armies in France，1918”. British Medical Journal 2，no.3019 （1918）：505-9. ［430］“Influenza Discussions”. American Journal of Public Health 9，no.2 （1919）：136. ［431］“Influenza：Its History，Nature，Cause and Treatment”. Book review. JAMA 63，no.3 （1914）：267. ［432］“Influenza：Kansas—Haskell”. Public Health Reports 33，no.14 （1918）：502. ［433］Jack，A. “Flu’s Unexpected Bonus”. British Medical Journal 339 （2009）：b3811. “James B. Herrick （1861-1954）”. JAMA 16，no.186 （1963）：722-23. ［434］Jefferson，T. “Influenza Vaccination：Policy versus Evidence”. British Medical Journal 333，no.7574 （2006）：912-15. ［435］Jefferson，T.，V. Demicheli，D. Rivetti，M. Jones，C. Di Pietrantonj，and A. Rivetti. “Antivirals for Influenza in Healthy Adults：Systematic Review”. Lancet 367，no.9507 （2006）：303-13. ［436］Jefferson，T.，and P. Doshi. “Multisystem Failure：The Story of Anti-influenza Drugs”. British Medical Journal 348 （2014）：g2263. ［437］Jefferson，T.，M. A. Jones，P. Doshi，C. B. Del Mar，R. Hama，M. J. Thompson，E. A. Spencer et al. “Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children”. Cochrane Database of Systematic Reviews 4 （2014）：CD008965. ［438］Jenner，E. An Inquiry into the Causes and Effects of the VariolaeVaccinae，a Disease Discovered in Some of the Western Counties of England，Particularly Gloucestershire，and Known by the Name of the Cow Pox. London：Sampson Low，1798. ［439］Kaiser，L.，C. Wat，T. Mills，P. Mahoney，P. Ward，and F. Hayden. “Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complicationsand Hospitalizations”. Archives of Internal Medicine 163，no.14 （2003）：1667-72. ［440］Kamat，S.，V. Maniaci，M. Y. Linares，and J. M. Lozano. “Pediatric Psychiatric Emergency Department Visits during a Full Moon.” Pediatric Emergency Care 30，no.12 （2014）：875-78. ［441］Kelly，H.，and K. Grant. “Interim Analysis of Pandemic Influenza （H1N1）2009 in Australia：Surveillance Trends，Age of Infection and Effectiveness of SeasonalVaccination”. Eurosurveillance 14，no.31 （2009）：1-5. ［442］Kennedy，D. “Better Never Than Late”. Science 310，no.5746 （2005）：195. ［443］Khan，A.，and W. Patrick. The Next Pandemic：On the Front Lines against Humankind’s Gravest Dangers. New York：Public Affairs，2016. ［444］Kilbourne，E. D. “Influenza Pandemics of the 20th Century”. Emerging Infectious Diseases 12，no.1 （2006）：9-14. ［445］Klein，H. A. “The Treatment of ‘Spanish Influenza’”. JAMA 71，no.18 （1918）：1510. ［446］Kluger，M. J. Fever：Its Biology，Evolution，and Function. Princeton，NJ：Princeton University Press，1979. ［447］Kmietowicz，Z. “Use Leftover Tamiflu to Grit Icy Roads，MP Suggests”. British Medical Journal 340 （2010）：c501. ［448］Kochanek，K. D.，S. L. Murphy，J. Xu，and B. Tejada-Vera. “Deaths：Final Data for 2014”. National Vital Statistics Reports 65，no.4 （2016）：1-122. ［449］Kolata，G. Flu：The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It. New York：Touchstone，2005. ［450］Lamb，F.，and E. Brannin. “The Epidemic Respiratory Infection at Camp Cody N.M”. JAMA 72，no.15 （1919）：1056-62. ［451］Langford，C. “Did the 1918-19 Influenza Pandemic Originate in China？” Populationand Development Review 31，no.3 （2005）：479-505. ［452］Langmuir，A. D.，T. D. Worthen，J. Solomon，C. G. Ray，and E. Petersen. “TheThucydides Syndrome. A New Hypothesis for the Cause of the Plague of Athens”. New England Journal of Medicine 313，no.16 （1985）：1027-30. ［453］Lazer，D.，R. Kennedy，G. King，and A. Vespignani. “The Parable of Google Flu：Traps in Big Data Analysis”. Science 343，no.6176 （2014）：1203-5. ［454］Leary，T. “The Use of the Influenza Vaccine in the Present Epidemic”. American Journal of Public Health 8，no.10 （1918）：754-55. ［455］Li，W.，S. K. Wong，F. Li，J. H. Kuhn，I. C. Huang，H. Choe，and M. Farzan. “Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus：Insight from ACE2-S-Protein Interactions”. Journal of Virology 80，no.9 （2006）：4211-19. ［456］Linder，J. A. “Vitamin D and the Cure for the Common Cold”. JAMA 308，no.13 （2012）：1375-76. ［457］Lowen，A. C.，S. Mubareka，J. Steel，and P. Palese. “Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature”. PLoS Pathogens 3，no.10 （2007）：1470-76. ［458］Malik，M. T.，A. Gumel，L. H. Thompson，T. Strome，and S. M. Mahmud. “‘Google Flu Trends’ and Emergency Department Triage Data Predicted the 2009 Pandemic H1N1 Waves in Manitoba”. Canadian Journal of Public Health 102，no.4 （2011）：294-97. ［459］Mamelund，S. E. “A Socially Neutral Disease？Individual Social Class，Household Wealth and Mortality from Spanish Influenza in Two Socially ContrastingParishes in Kristiania 1918-19”. Social Science & Medicine 62，no.4 （2006）：923-40. ［460］McCarthy，M. L.，S. L. Zeger，R. Ding，D. Aronsky，N. R. Hoot，and G. D. Kelen. “The Challenge of Predicting Demand for Emergency Department Services”. Academic Emergency Medicine 15，no.4 （2008）：337-46. ［461］McGuire，A.，M. Drummond，and S. Keeping. “Childhood and Adolescent Influenza Vaccination in Europe：A Review of Current Policies and Recommendations for the Future”. Expert Review of Vaccines 15，no.5 （2016）：659-70. ［462］McOscar，J. “Influenza in the Lay Press”. British Medical Journal 2，no.3019 （1918）：534. ［463］Mitton，S. Fred Hoyle：A Life in Science. Cambridge：Cambridge University Press，2011. ［464］Molinari，N. A.，I. R. Ortega-Sanchez，M. L. Messonnier，W. W. Thompson，P. M.Wortley，E. Weintraub，and C. B. Bridges. “The Annual Impact of Seasonal Influenza in the U.S.：Measuring Disease Burden and Costs”. Vaccine 25，no.27 （2007）：5086-96. ［465］Morens，D. M. “Death of a President”. New England Journal of Medicine 341，no.24 （1999）：1845-49. ［466］Morens，D. M.，and A. S. Fauci. “The 1918 Influenza Pandemic：Insights for the 21st Century”. Journal of Infectious Disease 195，no.7 （2007）：1019-28. ［467］Morens，D. M.，G. K. Folkers，and A. S. Fauci. “What Is a Pandemic？” Journal of Infectious Disease 200，no.7 （2009）：1018-21. ［468］Morens，D. M.，J. K. Taubenberger，and A. S. Fauci. “The Persistent Legacy of the 1918 Influenza Virus”. New England Journal of Medicine 361，no.3 （2009）：225-29. ［469］Moscona，A. “Neuraminidase Inhibitors for Influenza”. New England Journal of Medicine 353，no.13 （2005）：1363-73. ［470］Moser，M. R.，T. R. Bender，H. S. Margolis，G. R. Noble，A. P. Kendal，and D. G.Ritter. “An Outbreak of Influenza aboard a Commercial Airliner”. American Journal of Epidemiology 110，no.1 （1979）：1-6. ［471］Murdoch，D. R.，S. Slow，S. T. Chambers，L. C. Jennings，A. W. Stewart，P. C.Priest，C. M. Florkowski，J. H. Livesey，A. C. Camargo，and R. Scragg. “Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infectionsin Healthy Adults：The Vidaris Randomized Controlled Trial”. JAMA 308，no.13 （2012）：1333-39. ［472］Murray，C. J.，A. D. Lopez，B. Chin，D. Feehan，and K. H. Hill. “Estimation of Potential Global Pandemic Influenza Mortality on the Basis of Vital Registry Data from the 1918-20 Pandemic：A Quantitative Analysis”. Lancet 368，no.9554 （2006）：2211-18. ［473］Murthy，S.，and H. Wunsch. “Clinical Review：International Comparisons in Critical Care—Lessons Learned”. Critical Care 16，no.2 （2012）：218. ［474］Nguyen，J. L.，J. Schwartz，and D. W. Dockery. “The Relationship between Indoor and Outdoor Temperature，Apparent Temperature，Relative Humidity，and Absolute Humidity”. Indoor Air 24，no.1 （2014）：103-12. ［475］Nicolson，J. The Great Silence，1918-1920：Living in the Shadow of the Great War.London：Grove Press，2010. ［476］Noti，J. D.，F. M. Blachere，C. M. McMillen，W. G. Lindsley，M. L. Kashon，D. R.Slaughter，and D. H. Beezhold. “High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs”. PLoS One 8，no.2 （2013）：e57485. ［477］Olitsky，P.，and F. Gates. “Experimental Study of the Nasopharyngeal Secretions from Influenza Patients”. JAMA 74，no.22 （1920）：1497-99. ［478］Opie，E.，A. Freeman，F. Blake，J. Small，and T. Rivers. “Pneumonia at Camp Funston”. JAMA 72，no.2 （1919）：108-13. ［479］Ortiz，J. R.，L. Kamimoto，R. E. Aubert，J. Yao，D. K. Shay，J. S. Bresee，and R. S.Epstein. “Oseltamivir Prescribing in Pharmacy-Benefits Database，United States，2004-2005”. Emerging Infectious Diseases 14，no.8 （2008）：1280-83. ［480］Oshinsky，D. M. Polio：An American Story. Oxford：Oxford University Press，2005. ［481］Oxford，J. S. “The So-Called Great Spanish Influenza Pandemic of 1918 May Have Originated in France in 1916”. Philosophical Transactions of the Royal Society of London，Series B：Biological Sciences 356，no.1416 （2001）：1857-59. ［482］Patterson，K. D. Pandemic Influenza，1700-1900. Totowa，NJ：Rowman and Littlefield，1986. ［483］Patwardhan，A.，and R. Bilkovski. “Comparison：Flu Prescription Sales Data from a Retail Pharmacy in the U.S. with Google Flu Trends and U.S. ILINet （CDC）Data as Flu Activity Indicator”. PLoS One 7，no.8 （2012）：e43611. ［484］Petersen，W. F.，and S. A. Levinson. “The Therapeutic Effect of Venesection with Reference to Lobar Pneumonia”. JAMA 78，no.4 （1922）：257-58. ［485］Polgreen，P. M.，F. D. Nelson，and G. R. Neumann. “Use of Prediction Markets to Forecast Infectious Disease Activity”. Clinical Infectious Diseases 44，no.2 （2007）：272-79. ［486］Prager，F.，D. Wei，and A. Rose. “Total Economic Consequences of an Influenza Outbreak in the United States”. Risk Analysis 37，no.1 （2017）：4-19. ［487］Price，G. M. “Influenza—Destroyer and Teacher”. Survey 41，no.12 （1918）：367-69. ［488］“Proceedings of the Forty-Sixth Annual Meeting of the American Public Health Association”. American Journal of Public Health 9，no.2 （1919）：130-42. ［489］Reichert，T. A.，N. Sugaya，D. S. Fedson，W. P. Glezen，L. Simonsen，and M. Tashiro. “The Japanese Experience with Vaccinating Schoolchildren against Influenza”. New England Journal of Medicine 344，no.12 （2001）：889-96. ［490］Reid，A. H.，T. A. Janczewski，R. M. Lourens，A. J. Elliot，R. S. Daniels，C. L. Berry，J. S. Oxford，and J. K. Taubenberger. “1918 Influenza Pandemic Caused by Highly Conserved Viruses with Two Receptor-Binding Variants”. Emerging Infectious Diseases 9，no.10 （2003）：1249-53. ［491］Rice，E. W.，N. J. Adcock，M. Sivaganesan，J. D. Brown，D. E. Stallknecht，and D. E.Swayne. “Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus （H5N1）”. Emerging Infectious Diseases 13，no.10 （2007）：1568-70. ［492］Riedel，S. “Edward Jenner and the History of Smallpox and Vaccination.” Proceedings （Baylor University Medical Center） 18，no.1 （2005）：21-25. ［493］Robins，N. S. Copeland’s Cure：Homeopathy and the War between Conventional and Alternative Medicine. New York：Knopf，2005. ［494］Rose，A.，G. Oladosu，and S. Liao. “Business Interruption Impacts of a Terrorist Attack on the Electric Power System of Los Angeles：Customer Resilience to a Total Blackout”. Risk Analysis 27，no.3 （2009）：513-31. ［495］Rosenow，E. “Prophylactic Inoculation against Respiratory Infections”. JAMA 72，no.1 （1919）：31-34 ［496］Ross，R. S. “A Parlous State of Storm and Stress. The Life and Times of James B.Herrick”. Circulation 67，no.5 （1983）：955-59. ［497］Saketkhoo，K.，A. Januszkiewicz，and M. A. Sackner. “Effects of Drinking Hot Water，Cold Water，and Chicken Soup on Nasal Mucus Velocity and NasalAirflow Resistance”. Chest 74，no.4 （1978）：408-10. ［498］Saunders-Hastings，P. R.，and D. Krewski. “Reviewing the History of Pandemic Influenza：Understanding Patterns of Emergence and Transmission”. Pathogens 5，no.4 （2016）：66. ［499］Sencer，D. J.，and J. D. Millar. “Reflections on the 1976 Swine Flu Vaccination Program”. Emerging Infectious Diseases 12，no.1 （2006）：29-33. ［500］Shadrin，A. S.，I. G. Marinich，and L. Y. Taros. “Experimental and Epidemiological Estimation of Seasonal and Climato-Geographical Features of Non-Specific Resistance of the Organism to Influenza”. Journal of Hygiene，Epidemiology，Microbiology，and Immunology 21，no.2 （1977）：155-61. ［501］Shaman，J.，and A. Karspeck. “Forecasting Seasonal Outbreaks of Influenza”. Proceedings of the National Academy of Sciences 109，no.50 （2012）：20425-30. ［502］Shaman，J.，A. Karspeck，W. Yang，J. Tamerius，and M. Lipsitch. “Real-Time Influenza Forecasts during the 2012-2013 Season”. Nature Communications 4 （2013）：2837. ［503］Shanks，G. D.，S. Burroughs，J. D. Sohn，N. C. Waters，V. F. Smith，M. Waller，and J. F. Brundage. “Variable Mortality from the 1918-1919 Influenza Pandemic during Military Training”. Military Medicine 181，no.8 （2016）：878-82. ［504］Sherertz，R. J.，and H. J. Sherertz. “Influenza in the Preantibiotic Era”. Infectious Diseases in Clinical Practice 14，no.3 （2006）：127. ［505］Shortridge，K. F. “The 1918 ‘Spanish’ Flu：Pearls from Swine？” Nature Medicine 5，no.4 （1999）：384-85. ［506］Shrestha，S. S.，D. L. Swerdlow，R. H. Borse，V. S. Prabhu，L. Finelli，C. Y. Atkins，K. Owusu-Edusei et al. “Estimating the Burden of 2009 Pandemic Influenza A （H1N1）in the United States （April 2009-April 2010）”. Clinical Infectious Diseases 52，suppl.1 （2011）：S75-82. ［507］Shufflebotham，F. “Influenza among Poison Gas Workers”. British Medical Journal 1，no.3042 （1919）：478-79. ［508］Skowronski，D. M.，C. Chambers，G. De Serres，J. A. Dickinson，A. L. Winter，R. Hickman，T. Chan et al. “Early Season Co-circulation of Influenza A （H3N2）and B （Yamagata）：Interim Estimates of 2017/18 Vaccine Effectiveness，Canada，January 2018”. Eurosurveillance 23，no.5 （2018）：DOI：10.3201/eid1201.051254. ［509］Smith，D. C. “Quinine and Fever：The Development of the Effective Dosage”. Journal of the History of Medicine and Allied Sciences 31，no.3 （1976）：343-67. ［510］Smith，D. W.，and B. S. Bradshaw. “Variation in Life Expectancy during the Twentieth Century in the United States”. Demography 43，no.4 （2006）：647-57. ［511］Smith，W.，C. Andrewes，and P. Laidlaw. “A Virus Obtained from Influenza Patients”. Lancet 2，no.5723 （1933）：66-68. ［512］Sneader，W. Drug Discovery：A History. Hoboken，NJ：Wiley & Sons，2005. ［513］Sorbello，A.，S. C. Jones，W. Carter，K. Struble，R. Boucher，M. Truffa，D. Birnkrant et al. “Emergency Use Authorization for Intravenous Peramivir：Evaluation of Safety in the Treatment of Hospitalized Patients Infected with 2009 H1N1 Influenza A Virus”. Clinical Infectious Diseases 55，no.1 （2012）：1-7. ［514］Spurgeon，D. “Roche Canada Stops Distributing Oseltamivir”. British Medical Journal 331，no.7524 （2005）：1041. ［515］Starko，K. M. “Salicylates and Pandemic Influenza Mortality，1918-1919：Pharmacology，Pathology，and Historic Evidence”. Clinical Infectious Diseases 49，no.9 （2009）：1405-10. ［516］Stern，H. Theory and Practice of Bloodletting. New York：Rebman Company，1915. ［517］Stoecker，C.，N. Sanders，and A. Barreca. “Success Is Something to Sneeze At：Influenza Mortality in Regions That Send Teams to the Super Bowl”. Tulane Economics Working Paper Series 2015；Working Paper 1501. ［518］Sydenstricker，E. “The Incidence of Influenza among Persons of Different Economic Status during the Epidemic of 1918”. Public Health Reports 46，no.4 （1931）：154-70. ［519］Taubenberger，J. K. “The Origin and Virulence of the 1918 ‘Spanish’ InfluenzaVirus”. Proceedings of the American Philosophical Society 150，no.1 （2006）：86-112. ［520］Taubenberger，J. K.，J. V. Hultin，and D. M. Morens. “Discovery and Characterization of the 1918 Pandemic Influenza Virus in Historical Context”. Antiviral Therapy 12，no.4，part B （2007）：581-91. ［521］Taubenberger，J. K.，A. H. Reid，and T. G. Fanning. “Capturing a Killer Flu Virus.” Scientific American 292，no.1 （January 2005）：62-71. ［522］Taubenberger，J. K.，A. H. Reid，A. E. Krafft，K. E. Bijwaard，and T. G. Fanning. “Initial Genetic Characterization of the 1918 ‘Spanish’ Influenza Virus”. Science 275，no.5307 （1997）：1793-96. ［523］Taubenberger，J. K.，A. H. Reid，R. M. Lourens，R. Wang，G. Jin，and T. G. Fanning. “Characterization of the 1918 Influenza Virus Polymerase Genes”. Nature 437，no.7060 （2005）：889-93. ［524］Thompson，W. W.，D. K. Shay，E. Weintraub，L. Brammer，N. Cox，L. J. Anderson，and K. Fukuda. “Mortality Associated with Influenza and Respiratory Syncytial Virus in the United States”. JAMA 289，no.2 （2003）：179-86. ［525］Tiwari，Y.，S. Goel，and A. Singh. “Arrival Time Pattern and Waiting Time Distribution of Patients in the Emergency Outpatient Department of a Tertiary Level Health Care Institution of North India”. Journal of Emergencies，Trauma，and Shock 7，no.3 （2014）：160-65. ［526］Tumpey，T. M.，C. F. Basler，P. V. Aguilar，H. Zeng，A. Solorzano，D. E. Swayne，N. J. Cox et al. “Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus”. Science 310，no.5745 （2005）：77-80. ［527］“Undetermined Disease—Valencia”. Public Health Reports 33，no.26 （1918）：1087. ［528］Urashima，M.，T. Segawa，M. Okazaki，M. Kurihara，Y. Wada，and H. Ida. “Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren”. American Journal of Clinical Nutrition 91，no.5 （2010）：1255-60. ［529］Valdivia，A.，J. Lopez-Alcalde，M. Vicente，M. Pichiule，M. Ruiz，and M. Ordobas. “Monitoring Influenza Activity in Europe with Google Flu Trends：Comparison with the Findings of Sentinel Physician Networks—Results for 2009-10”. Eurosurveillance 15，no.29 （2010）：ii：19621. ［530］Vaughan，V. C. Doctor’s Memories. New York：Bobbs-Merrill Company，1926. ［531］Von Alvensleben，A. “Influenza According to Hoyle”. Nature 344，no.6265 （1990）：374. ［532］Watanabe，T.，G. Zhong，C. A. Russell，N. Nakajima，M. Hatta，A. Hanson，R.McBride，et al. “Circulating Avian Influenza Viruses Closely Related to the 1918 Virus Have Pandemic Potential”. Cell Host & Microbe 15，no.6 （2014）：692-705. ［533］Welch，S. J.，S. S. Jones，and T. Allen. “Mapping the 24-Hour Emergency Department Cycle to Improve Patient Flow”. Joint Commission Journal on Qualityand Patient Safety 33，no.5 （2007）：247-55. ［534］Welsch，R. A Treasury of Nebraska Pioneer Folklore. Lincoln：University of Nebraska Press，1967. ［535］Winternitz，M. C.，I. M. Wason，and F. P. McNamara. The Pathology of Influenza. New Haven，CT：Yale University Press，1920. ［536］Wootton，D. Bad Medicine：Doctors Doing Harm since Hippocrates. Oxford：Oxford University Press，2006. ［537］Yamanouchi，T.，K. Sakakami，and S. Iwashima. “The Infecting Agent in Influenza：An Experimental Research”. Lancet 193，no.4997 （1919）：971. ［538］Yang，Y.，A. V. Diez Roux，and C. R. Bingham. “Variability and Seasonality of Active Transportation in USA：Evidence from the 2001 NHTS”. International Journal of Behavioral Nutrition and Physical Activity 8 （2011）：96. ［539］Zadshir，A.，N. Tareen，D. Pan，K. Norris，and D. Martins. “The Prevalence of Hypovitaminosis D among U.S. Adults：Data from the NHANES III”. Ethnicity & Disease 15，no.4，suppl.5 （2005）：S5-97-101. ［540］Zhang，X.，M. I. Meltzer，and P. M. Wortley. “FluSurge——a Tool to Estimate Demand for Hospital Services during the Next Pandemic Influenza”. Medical Decision Making 26，no.6 （2006）：617-23.